ONTOLOGY REPORT - ANNOTATIONS
| Term: | chlorpyrifos |
|
| Accession: | CHEBI:34631
|
browse the term
|
| Definition: | An organochlorine acaricide that has formula C9H11Cl3NO3PS. |
| Synonyms: | exact_synonym: | O,O-diethyl O-(3,5,6-trichloropyridin-2-yl) phosphorothioate |
| | related_synonym: | C9H11Cl3NO3PS; CCOP(=S)(OCC)Oc1nc(Cl)c(Cl)cc1Cl; Chlorpyrifos-ethyl; Chlorpyriphos; InChI=1S/C9H11Cl3NO3PS/c1-3-14-17(18,15-4-2)16-9-7(11)5-6(10)8(12)13-9/h5H,3-4H2,1-2H3; InChIKey=SBPBAQFWLVIOKP-UHFFFAOYSA-N; O,O-diethyl O-(3,5,6-trichloropyridin-2-yl) thiophosphate; Phosphorothioic acid, O,O-diethyl O-(3,5,6-trichloro-2-pyridinyl) ester; Trichlorpyrphos; m-Chlorpyrifos; o,o-Diethyl-o-(3,5,6-trichloro-2-pyridyl)phosphorothioate |
| | xref_casrn: | 2921-88-2 |
| | xref: | Beilstein:1545756 "Beilstein Registry Number"; ChEMBL:543151 "ChEMBL COMPOUND"; ChemIDplus:2921-88-2 "CAS Registry Number"; KEGG COMPOUND:2921-88-2 "CAS Registry Number"; KEGG COMPOUND:C14322 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D004390 |
| | xref: | NIST Chemistry WebBook:2921-88-2 "CAS Registry Number" |
|
|
chlorpyrifos
|
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
affects binding |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
increases expression |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abcg8 |
ATP-binding cassette, subfamily G (WHITE), member 8 |
|
increases expression |
EXP |
6 |
8,064,631 |
8,083,271 |
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Acmsd |
aminocarboxymuconate semialdehyde decarboxylase |
|
increases expression |
EXP |
13 |
40,547,366 |
40,573,698 |
RGD:6480464 |
CTD |
| G |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
|
increases expression |
EXP |
1 |
261,554,383 |
261,599,373 |
RGD:6480464 |
CTD |
| G |
Adcy1 |
adenylate cyclase 1 (brain) |
|
decreases expression |
EXP |
14 |
87,812,256 |
87,923,402 |
RGD:6480464 |
CTD |
| G |
Adcy4 |
adenylate cyclase 4 |
|
increases expression |
EXP |
15 |
33,930,531 |
33,946,352 |
RGD:6480464 |
CTD |
| G |
Adcy9 |
adenylate cyclase 9 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenoceptor alpha 1A |
|
decreases expression |
EXP |
15 |
46,173,429 |
46,263,198 |
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenoceptor alpha 1A |
|
affects expression |
EXP |
15 |
46,173,429 |
46,263,198 |
RGD:6480464 |
CTD |
| G |
Adra1d |
adrenoceptor alpha 1D |
|
affects expression |
EXP |
3 |
119,279,974 |
119,295,985 |
RGD:6480464 |
CTD |
| G |
Adra1d |
adrenoceptor alpha 1D |
|
decreases expression |
EXP |
3 |
119,279,974 |
119,295,985 |
RGD:6480464 |
CTD |
| G |
Adra2a |
adrenoceptor alpha 2A |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Adra2a |
adrenoceptor alpha 2A |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Adra2c |
adrenoceptor alpha 2C |
|
decreases expression |
EXP |
14 |
81,107,907 |
81,109,610 |
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
decreases expression |
EXP |
1 |
263,025,655 |
263,027,055 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
affects expression |
EXP |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
increases expression |
EXP |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
decreases expression |
EXP |
16 |
69,163,620 |
69,166,384 |
RGD:6480464 |
CTD |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
affects expression |
EXP |
16 |
69,163,620 |
69,166,384 |
RGD:6480464 |
CTD |
| G |
Adrbk1 |
adrenergic, beta, receptor kinase 1 |
|
multiple interactions |
EXP |
1 |
206,873,002 |
206,892,868 |
RGD:6480464 |
CTD |
| G |
Adrbk1 |
adrenergic, beta, receptor kinase 1 |
|
decreases expression |
EXP |
1 |
206,873,002 |
206,892,868 |
RGD:6480464 |
CTD |
| G |
Adrbk1 |
adrenergic, beta, receptor kinase 1 |
|
increases expression |
EXP |
1 |
206,873,002 |
206,892,868 |
RGD:6480464 |
CTD |
| G |
Adrbk2 |
adrenergic, beta, receptor kinase 2 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Adrbk2 |
adrenergic, beta, receptor kinase 2 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Agrn |
agrin |
|
decreases expression |
ISO |
5 |
172,999,420 |
173,020,764 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases expression |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases expression |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Aktip |
AKT interacting protein |
|
decreases expression |
ISO |
19 |
17,035,220 |
17,045,096 |
RGD:6480464 |
CTD |
| G |
Alcam |
activated leukocyte cell adhesion molecule |
|
decreases expression |
EXP |
11 |
49,424,243 |
49,630,071 |
RGD:6480464 |
CTD |
| G |
Aldh7a1 |
aldehyde dehydrogenase 7 family, member A1 |
|
decreases expression |
EXP |
18 |
52,300,899 |
52,333,149 |
RGD:6480464 |
CTD |
| G |
Alk |
anaplastic lymphoma receptor tyrosine kinase |
|
increases expression |
ISO |
6 |
23,009,061 |
23,730,939 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
multiple interactions |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Amigo1 |
adhesion molecule with Ig like domain 1 |
|
increases expression |
ISO |
2 |
203,752,632 |
203,754,113 |
RGD:6480464 |
CTD |
| G |
Amigo3 |
adhesion molecule with Ig like domain 3 |
|
increases expression |
EXP |
8 |
113,321,258 |
113,322,784 |
RGD:6480464 |
CTD |
| G |
Ap1b1 |
adaptor-related protein complex 1, beta 1 subunit |
|
decreases expression |
EXP |
14 |
85,663,840 |
85,695,487 |
RGD:6480464 |
CTD |
| G |
Ap1g1 |
adaptor-related protein complex 1, gamma 1 subunit |
|
decreases expression |
EXP |
19 |
39,676,021 |
39,734,854 |
RGD:6480464 |
CTD |
| G |
Ap1g2 |
adaptor-related protein complex 1, gamma 2 subunit |
|
affects expression |
EXP |
15 |
33,205,056 |
33,212,801 |
RGD:6480464 |
CTD |
| G |
Ap1m1 |
adaptor-related protein complex 1, mu 1 subunit |
|
decreases expression |
EXP |
16 |
18,009,300 |
18,024,765 |
RGD:6480464 |
CTD |
| G |
Ap2b1 |
adaptor-related protein complex 2, beta 1 subunit |
|
decreases expression |
ISO |
10 |
71,386,233 |
71,488,000 |
RGD:6480464 |
CTD |
| G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
decreases expression |
ISO |
7 |
27,932,908 |
28,020,533 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases activity |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Arc |
activity-regulated cytoskeleton-associated protein |
|
decreases expression |
EXP |
7 |
112,771,937 |
112,775,381 |
RGD:6480464 |
CTD |
| G |
Arih1 |
ariadne homolog, ubiquitin-conjugating enzyme E2 binding protein, 1 (Drosophila) |
|
decreases expression |
ISO |
8 |
63,201,871 |
63,305,302 |
RGD:6480464 |
CTD |
| G |
Arih2 |
ariadne homolog 2 (Drosophila) |
|
increases expression |
ISO |
8 |
113,647,000 |
113,705,922 |
RGD:6480464 |
CTD |
| G |
Arl5a |
ADP-ribosylation factor-like 5A |
|
increases expression |
EXP |
3 |
33,905,755 |
33,926,681 |
RGD:6480464 |
CTD |
| G |
Arpc5l |
actin related protein 2/3 complex, subunit 5-like |
|
decreases expression |
EXP |
3 |
18,798,930 |
18,801,987 |
RGD:6480464 |
CTD |
| G |
Arrb1 |
arrestin, beta 1 |
|
decreases expression |
EXP |
1 |
156,871,564 |
156,937,540 |
RGD:6480464 |
CTD |
| G |
Asic1 |
acid-sensing (proton-gated) ion channel 1 |
|
decreases expression |
EXP |
7 |
138,414,656 |
138,443,272 |
RGD:6480464 |
CTD |
| G |
Aspm |
asp (abnormal spindle) homolog, microcephaly associated (Drosophila) |
|
decreases expression |
ISO |
13 |
52,811,658 |
52,860,925 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
increases expression |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
multiple interactions |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atp13a1 |
ATPase type 13A1 |
|
decreases expression |
EXP |
16 |
20,100,481 |
20,116,536 |
RGD:6480464 |
CTD |
| G |
Atp2b4 |
ATPase, Ca++ transporting, plasma membrane 4 |
|
decreases expression |
EXP |
13 |
46,631,205 |
46,697,214 |
RGD:6480464 |
CTD |
| G |
Atp6v1c1 |
ATPase, H+ transporting, lysosomal V1 subunit C1 |
|
increases expression |
EXP |
7 |
74,341,301 |
74,378,806 |
RGD:6480464 |
CTD |
| G |
Avpr1a |
arginine vasopressin receptor 1A |
|
decreases expression |
EXP |
7 |
62,225,537 |
62,229,461 |
RGD:6480464 |
CTD |
| G |
Axin2 |
axin 2 |
|
decreases expression |
EXP |
10 |
98,294,466 |
98,321,830 |
RGD:6480464 |
CTD |
| G |
Baalc |
brain and acute leukemia, cytoplasmic |
|
increases expression |
EXP |
7 |
74,426,267 |
74,499,551 |
RGD:6480464 |
CTD |
| G |
Bag1 |
BCL2-associated athanogene |
|
decreases expression |
EXP |
5 |
58,329,720 |
58,342,293 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
decreases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bche |
butyrylcholinesterase |
|
decreases activity |
ISO |
2 |
164,329,613 |
164,427,994 |
RGD:6480464 |
CTD |
| G |
Bche |
butyrylcholinesterase |
|
affects expression |
EXP |
2 |
164,329,613 |
164,427,994 |
RGD:6480464 |
CTD |
| G |
Bche |
butyrylcholinesterase |
|
multiple interactions |
EXP |
2 |
164,329,613 |
164,427,994 |
RGD:6480464 |
CTD |
| G |
Bche |
butyrylcholinesterase |
|
decreases activity |
EXP |
2 |
164,329,613 |
164,427,994 |
RGD:6480464 |
CTD |
| G |
Bche |
butyrylcholinesterase |
|
decreases activity |
ISO |
2 |
164,329,613 |
164,427,994 |
RGD:6480464 |
CTD |
| G |
Bche |
butyrylcholinesterase |
|
decreases activity |
ISO |
2 |
164,329,613 |
164,427,994 |
RGD:6480464 |
CTD |
| G |
Bche |
butyrylcholinesterase |
|
decreases activity |
ISO |
2 |
164,329,613 |
164,427,994 |
RGD:6480464 |
CTD |
| G |
Bche |
butyrylcholinesterase |
|
decreases expression |
ISO |
2 |
164,329,613 |
164,427,994 |
RGD:6480464 |
CTD |
| G |
Bche |
butyrylcholinesterase |
|
decreases activity |
EXP |
2 |
164,329,613 |
164,427,994 |
RGD:6480464 |
CTD |
| G |
Bche |
butyrylcholinesterase |
|
decreases activity |
ISO |
2 |
164,329,613 |
164,427,994 |
RGD:6480464 |
CTD |
| G |
Bche |
butyrylcholinesterase |
|
multiple interactions |
EXP |
2 |
164,329,613 |
164,427,994 |
RGD:6480464 |
CTD |
| G |
Bche |
butyrylcholinesterase |
|
decreases activity |
EXP |
2 |
164,329,613 |
164,427,994 |
RGD:6480464 |
CTD |
| G |
Bche |
butyrylcholinesterase |
|
decreases activity |
ISO |
2 |
164,329,613 |
164,427,994 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
increases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcr |
breakpoint cluster region |
|
increases expression |
ISO |
20 |
13,972,773 |
14,097,816 |
RGD:6480464 |
CTD |
| G |
Bcr |
breakpoint cluster region |
|
decreases expression |
EXP |
20 |
13,972,773 |
14,097,816 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Bex1 |
brain expressed, X-linked 1 |
|
decreases expression |
EXP |
X |
123,527,737 |
123,529,133 |
RGD:6480464 |
CTD |
| G |
Bex4 |
brain expressed, X-linked 4 |
|
decreases expression |
EXP |
X |
123,442,511 |
123,443,772 |
RGD:6480464 |
CTD |
| G |
Birc6 |
baculoviral IAP repeat-containing 6 |
|
increases expression |
EXP |
6 |
20,655,186 |
20,848,961 |
RGD:6480464 |
CTD |
| G |
Bst1 |
bone marrow stromal cell antigen 1 |
|
decreases expression |
EXP |
14 |
72,404,263 |
72,414,500 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
decreases expression |
EXP |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
|
decreases expression |
EXP |
4 |
154,895,691 |
155,517,389 |
RGD:6480464 |
CTD |
| G |
Calr |
calreticulin |
|
increases expression |
EXP |
19 |
24,964,775 |
24,969,670 |
RGD:6480464 |
CTD |
| G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
|
decreases expression |
ISO |
18 |
56,879,247 |
56,948,537 |
RGD:6480464 |
CTD |
| G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
|
increases expression |
ISO |
14 |
86,632,686 |
86,721,281 |
RGD:6480464 |
CTD |
| G |
Cartpt |
CART prepropeptide |
|
decreases expression |
EXP |
2 |
30,889,817 |
30,891,837 |
RGD:6480464 |
CTD |
| G |
Casp1 |
caspase 1 |
|
multiple interactions |
ISO |
8 |
2,027,976 |
2,036,872 |
RGD:6480464 |
CTD |
| G |
Casp12 |
caspase 12 |
|
affects expression |
EXP |
8 |
2,082,933 |
2,110,511 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
affects expression |
EXP |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases activity |
EXP |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casq2 |
calsequestrin 2 (cardiac muscle) |
|
increases expression |
EXP |
2 |
197,182,938 |
197,239,201 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cbx8 |
chromobox homolog 8 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccar1 |
cell division cycle and apoptosis regulator 1 |
|
increases expression |
ISO |
20 |
29,997,000 |
30,039,602 |
RGD:6480464 |
CTD |
| G |
Ccdc90b |
coiled-coil domain containing 90B |
|
decreases expression |
EXP |
1 |
149,410,497 |
149,424,055 |
RGD:6480464 |
CTD |
| G |
Cck |
cholecystokinin |
|
decreases expression |
EXP |
8 |
126,492,636 |
126,499,220 |
RGD:6480464 |
CTD |
| G |
Cck |
cholecystokinin |
|
increases expression |
ISO |
8 |
126,492,636 |
126,499,220 |
RGD:6480464 |
CTD |
| G |
Ccl4 |
chemokine (C-C motif) ligand 4 |
|
increases expression |
ISO |
10 |
71,759,643 |
71,761,115 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
decreases expression |
EXP |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
decreases expression |
ISO |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
decreases expression |
ISO |
4 |
163,523,817 |
163,546,501 |
RGD:6480464 |
CTD |
| G |
Ccndbp1 |
cyclin D-type binding-protein 1 |
|
increases expression |
EXP |
3 |
107,787,374 |
107,800,798 |
RGD:6480464 |
CTD |
| G |
Cd47 |
Cd47 molecule |
|
decreases expression |
EXP |
11 |
52,098,355 |
52,158,169 |
RGD:6480464 |
CTD |
| G |
Cdc23 |
cell division cycle 23 |
|
decreases expression |
ISO |
18 |
27,108,516 |
27,128,285 |
RGD:6480464 |
CTD |
| G |
Cdc42bpa |
CDC42 binding protein kinase alpha |
|
decreases expression |
EXP |
13 |
95,640,342 |
95,865,501 |
RGD:6480464 |
CTD |
| G |
Cdc6 |
cell division cycle 6 |
|
decreases expression |
ISO |
10 |
87,684,493 |
87,697,865 |
RGD:6480464 |
CTD |
| G |
Cdca2 |
cell division cycle associated 2 |
|
decreases expression |
ISO |
15 |
47,225,711 |
47,271,412 |
RGD:6480464 |
CTD |
| G |
Cdh13 |
cadherin 13 |
|
decreases expression |
EXP |
19 |
48,507,173 |
49,575,123 |
RGD:6480464 |
CTD |
| G |
Cdh22 |
cadherin 22 |
|
decreases expression |
EXP |
3 |
156,155,004 |
156,275,540 |
RGD:6480464 |
CTD |
| G |
Cdk15 |
cyclin-dependent kinase 15 |
|
increases expression |
EXP |
9 |
57,840,625 |
57,930,096 |
RGD:6480464 |
CTD |
| G |
Celf2 |
CUGBP, Elav-like family member 2 |
|
decreases expression |
EXP |
17 |
82,708,354 |
83,025,139 |
RGD:6480464 |
CTD |
| G |
Cep55 |
centrosomal protein 55 |
|
decreases expression |
ISO |
1 |
242,382,809 |
242,398,281 |
RGD:6480464 |
CTD |
| G |
Ces1c |
carboxylesterase 1C |
|
decreases response to substance |
ISO |
19 |
14,981,499 |
15,021,203 |
RGD:6480464 |
CTD |
| G |
Chat |
choline O-acetyltransferase |
|
decreases expression |
EXP |
16 |
7,913,026 |
7,965,985 |
RGD:6480464 |
CTD |
| G |
Chat |
choline O-acetyltransferase |
|
decreases expression |
EXP |
16 |
7,913,026 |
7,965,985 |
RGD:6480464 |
CTD |
| G |
Chek1 |
checkpoint kinase 1 |
|
decreases expression |
ISO |
8 |
37,954,322 |
37,974,748 |
RGD:6480464 |
CTD |
| G |
Chga |
chromogranin A (parathyroid secretory protein 1) |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Chga |
chromogranin A (parathyroid secretory protein 1) |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Chgb |
chromogranin B (secretogranin 1) |
|
increases expression |
EXP |
3 |
120,571,736 |
120,584,874 |
RGD:6480464 |
CTD |
| G |
Chpt1 |
choline phosphotransferase 1 |
|
increases expression |
ISO |
7 |
25,171,417 |
25,198,384 |
RGD:6480464 |
CTD |
| G |
Chrm1 |
cholinergic receptor, muscarinic 1 |
|
decreases activity |
EXP |
1 |
211,351,738 |
211,353,120 |
RGD:6480464 |
CTD |
| G |
Chrm1 |
cholinergic receptor, muscarinic 1 |
|
affects expression |
EXP |
1 |
211,351,738 |
211,353,120 |
RGD:6480464 |
CTD |
| G |
Chrm1 |
cholinergic receptor, muscarinic 1 |
|
decreases expression |
EXP |
1 |
211,351,738 |
211,353,120 |
RGD:6480464 |
CTD |
| G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
|
multiple interactions |
EXP |
4 |
63,911,292 |
63,913,354 |
RGD:6480464 |
CTD |
| G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
|
decreases activity |
EXP |
4 |
63,911,292 |
63,913,354 |
RGD:6480464 |
CTD |
| G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
|
increases expression |
EXP |
4 |
63,911,292 |
63,913,354 |
RGD:6480464 |
CTD |
| G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
|
increases expression |
EXP |
4 |
63,911,292 |
63,913,354 |
RGD:6480464 |
CTD |
| G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
|
decreases activity |
EXP |
17 |
71,214,906 |
71,218,463 |
RGD:6480464 |
CTD |
| G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
|
decreases expression |
EXP |
17 |
71,214,906 |
71,218,463 |
RGD:6480464 |
CTD |
| G |
Chrm4 |
cholinergic receptor, muscarinic 4 |
|
decreases activity |
EXP |
3 |
76,301,988 |
76,309,729 |
RGD:6480464 |
CTD |
| G |
Chrm5 |
cholinergic receptor, muscarinic 5 |
|
affects expression |
EXP |
3 |
98,326,809 |
98,378,531 |
RGD:6480464 |
CTD |
| G |
Chrm5 |
cholinergic receptor, muscarinic 5 |
|
decreases expression |
EXP |
3 |
98,326,809 |
98,378,531 |
RGD:6480464 |
CTD |
| G |
Chrna10 |
cholinergic receptor, nicotinic, alpha 10 (neuronal) |
|
increases expression |
EXP |
1 |
159,590,904 |
159,595,101 |
RGD:6480464 |
CTD |
| G |
Chrna10 |
cholinergic receptor, nicotinic, alpha 10 (neuronal) |
|
increases expression |
EXP |
1 |
159,590,904 |
159,595,101 |
RGD:6480464 |
CTD |
| G |
Chrna5 |
cholinergic receptor, nicotinic, alpha 5 (neuronal) |
|
decreases expression |
EXP |
8 |
58,538,002 |
58,566,388 |
RGD:6480464 |
CTD |
| G |
Chrna6 |
cholinergic receptor, nicotinic, alpha 6 (neuronal) |
|
affects expression |
EXP |
16 |
69,012,201 |
69,018,901 |
RGD:6480464 |
CTD |
| G |
Chrna7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
|
decreases expression |
EXP |
1 |
117,587,580 |
117,716,267 |
RGD:6480464 |
CTD |
| G |
Chrna7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
|
affects expression |
EXP |
1 |
117,587,580 |
117,716,267 |
RGD:6480464 |
CTD |
| G |
Chrna9 |
cholinergic receptor, nicotinic, alpha 9 (neuronal) |
|
affects expression |
EXP |
14 |
44,906,566 |
44,913,821 |
RGD:6480464 |
CTD |
| G |
Chrnb2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) |
|
increases expression |
EXP |
2 |
181,961,373 |
181,969,581 |
RGD:6480464 |
CTD |
| G |
Chrnb3 |
cholinergic receptor, nicotinic, beta 3 (neuronal) |
|
affects expression |
EXP |
16 |
69,028,625 |
69,069,274 |
RGD:6480464 |
CTD |
| G |
Chrnb4 |
cholinergic receptor, nicotinic, beta 4 (neuronal) |
|
decreases expression |
EXP |
8 |
58,586,961 |
58,605,545 |
RGD:6480464 |
CTD |
| G |
Chrnd |
cholinergic receptor, nicotinic, delta (muscle) |
|
affects expression |
EXP |
9 |
85,996,421 |
86,004,839 |
RGD:6480464 |
CTD |
| G |
Chrne |
cholinergic receptor, nicotinic, epsilon (muscle) |
|
affects expression |
EXP |
10 |
57,497,192 |
57,501,511 |
RGD:6480464 |
CTD |
| G |
Chrng |
cholinergic receptor, nicotinic, gamma (muscle) |
|
decreases expression |
EXP |
9 |
86,012,089 |
86,018,199 |
RGD:6480464 |
CTD |
| G |
Cinp |
cyclin-dependent kinase 2-interacting protein |
|
increases expression |
EXP |
6 |
135,595,588 |
135,609,484 |
RGD:6480464 |
CTD |
| G |
Clcn3 |
chloride channel, voltage-sensitive 3 |
|
decreases expression |
EXP |
16 |
32,447,259 |
32,518,533 |
RGD:6480464 |
CTD |
| G |
Clip3 |
CAP-GLY domain containing linker protein 3 |
|
increases expression |
ISO |
1 |
85,238,779 |
85,253,538 |
RGD:6480464 |
CTD |
| G |
Cnot4 |
CCR4-NOT transcription complex, subunit 4 |
|
decreases expression |
ISO |
4 |
62,437,688 |
62,548,524 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
increases expression |
EXP |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Cpeb1 |
cytoplasmic polyadenylation element binding protein 1 |
|
increases expression |
EXP |
1 |
137,556,766 |
137,666,929 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
decreases expression |
ISO |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Crh |
corticotropin releasing hormone |
|
increases expression |
EXP |
2 |
104,764,023 |
104,765,887 |
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
increases expression |
ISO |
8 |
54,107,824 |
54,111,502 |
RGD:6480464 |
CTD |
| G |
Csde1 |
cold shock domain containing E1, RNA binding |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
EXP |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
decreases activity |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
decreases activity |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
affects metabolic processing |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases activity |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases expression |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
decreases activity |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
affects metabolic processing |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
multiple interactions |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
multiple interactions |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
affects metabolic processing |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
decreases sulfation |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
affects metabolic processing |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases metabolic processing |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
multiple interactions |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
decreases activity |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases activity |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
multiple interactions |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
|
multiple interactions |
ISO |
1 |
81,084,984 |
81,185,251 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
affects metabolic processing |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c7 |
cytochrome P450, family 2, subfamily c, polypeptide 7 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2d3 |
cytochrome P450, family 2, subfamily d, polypeptide 3 |
|
multiple interactions |
EXP |
7 |
120,778,783 |
120,783,140 |
RGD:6480464 |
CTD |
| G |
Cyp2d3 |
cytochrome P450, family 2, subfamily d, polypeptide 3 |
|
increases oxidation |
EXP |
7 |
120,778,783 |
120,783,140 |
RGD:6480464 |
CTD |
| G |
Cyp2d3 |
cytochrome P450, family 2, subfamily d, polypeptide 3 |
|
increases expression |
ISO |
7 |
120,778,783 |
120,783,140 |
RGD:6480464 |
CTD |
| G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
increases oxidation |
EXP |
7 |
120,742,273 |
120,752,274 |
RGD:6480464 |
CTD |
| G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
increases expression |
ISO |
7 |
120,742,273 |
120,752,274 |
RGD:6480464 |
CTD |
| G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
multiple interactions |
EXP |
7 |
120,742,273 |
120,752,274 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases activity |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases metabolic processing |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
decreases activity |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
affects metabolic processing |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
decreases activity |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
decreases activity |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
affects metabolic processing |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
increases expression |
ISO |
12 |
17,164,384 |
17,204,589 |
RGD:6480464 |
CTD |
| G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
affects metabolic processing |
ISO |
12 |
17,164,384 |
17,204,589 |
RGD:6480464 |
CTD |
| G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
affects metabolic processing |
ISO |
12 |
17,164,384 |
17,204,589 |
RGD:6480464 |
CTD |
| G |
Dbh |
dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
|
increases expression |
EXP |
3 |
6,052,706 |
6,069,826 |
RGD:6480464 |
CTD |
| G |
Dbh |
dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
|
increases expression |
EXP |
3 |
6,052,706 |
6,069,826 |
RGD:6480464 |
CTD |
| G |
Ddx39b |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B |
|
increases expression |
EXP |
20 |
3,611,128 |
3,623,578 |
RGD:6480464 |
CTD |
| G |
Det1 |
de-etiolated homolog 1 (Arabidopsis) |
|
decreases expression |
ISO |
1 |
134,552,235 |
134,566,070 |
RGD:6480464 |
CTD |
| G |
Dkk1 |
dickkopf WNT signaling pathway inhibitor 1 |
|
increases expression |
EXP |
1 |
234,392,743 |
234,396,426 |
RGD:6480464 |
CTD |
| G |
Dkk3 |
dickkopf WNT signaling pathway inhibitor 3 |
|
increases expression |
EXP |
1 |
169,924,617 |
169,964,692 |
RGD:6480464 |
CTD |
| G |
Dlg1 |
discs, large homolog 1 (Drosophila) |
|
decreases expression |
EXP |
11 |
70,735,283 |
70,930,374 |
RGD:6480464 |
CTD |
| G |
Dlg2 |
discs, large homolog 2 (Drosophila) |
|
decreases expression |
EXP |
1 |
147,887,478 |
149,274,633 |
RGD:6480464 |
CTD |
| G |
Dlg4 |
discs, large homolog 4 (Drosophila) |
|
decreases expression |
ISO |
10 |
56,864,459 |
56,890,626 |
RGD:6480464 |
CTD |
| G |
Dlgap2 |
discs, large (Drosophila) homolog-associated protein 2 |
|
decreases expression |
EXP |
16 |
79,613,016 |
80,328,220 |
RGD:6480464 |
CTD |
| G |
Dnajb1 |
DnaJ (Hsp40) homolog, subfamily B, member 1 |
|
decreases expression |
EXP |
19 |
26,213,739 |
26,217,480 |
RGD:6480464 |
CTD |
| G |
Dnal1 |
dynein, axonemal, light chain 1 |
|
decreases expression |
EXP |
6 |
108,164,166 |
108,190,405 |
RGD:6480464 |
CTD |
| G |
Dnm1l |
dynamin 1-like |
|
decreases expression |
EXP |
11 |
86,617,236 |
86,665,861 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
increases expression |
EXP |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
decreases expression |
EXP |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd4 |
dopamine receptor D4 |
|
affects expression |
EXP |
1 |
201,485,597 |
201,488,784 |
RGD:6480464 |
CTD |
| G |
Drd4 |
dopamine receptor D4 |
|
affects expression |
EXP |
1 |
201,485,597 |
201,488,784 |
RGD:6480464 |
CTD |
| G |
Dtnb |
dystrobrevin, beta |
|
decreases expression |
EXP |
6 |
26,542,148 |
26,742,199 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
increases expression |
ISO |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
decreases expression |
EXP |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dvl1 |
dishevelled segment polarity protein 1 |
|
increases expression |
EXP |
5 |
172,705,951 |
172,717,626 |
RGD:6480464 |
CTD |
| G |
Dvl1 |
dishevelled segment polarity protein 1 |
|
decreases expression |
ISO |
5 |
172,705,951 |
172,717,626 |
RGD:6480464 |
CTD |
| G |
Dvl2 |
dishevelled segment polarity protein 2 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Dzip3 |
DAZ interacting zinc finger protein 3 |
|
decreases expression |
ISO |
11 |
53,065,385 |
53,134,110 |
RGD:6480464 |
CTD |
| G |
E4f1 |
E4F transcription factor 1 |
|
increases expression |
ISO |
10 |
13,701,558 |
13,713,008 |
RGD:6480464 |
CTD |
| G |
Edc4 |
enhancer of mRNA decapping 4 |
|
increases expression |
EXP |
19 |
35,719,306 |
35,731,298 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
decreases expression |
EXP |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Efhd1 |
EF-hand domain family, member D1 |
|
increases expression |
ISO |
9 |
86,076,009 |
86,124,552 |
RGD:6480464 |
CTD |
| G |
Efnb1 |
ephrin B1 |
|
decreases expression |
ISO |
X |
87,163,176 |
87,175,982 |
RGD:6480464 |
CTD |
| G |
Egr2 |
early growth response 2 |
|
decreases expression |
ISO |
20 |
21,883,885 |
21,888,177 |
RGD:6480464 |
CTD |
| G |
Eif3a |
eukaryotic translation initiation factor 3, subunit A |
|
decreases expression |
EXP |
1 |
267,369,497 |
267,399,705 |
RGD:6480464 |
CTD |
| G |
Eif3a |
eukaryotic translation initiation factor 3, subunit A |
|
decreases expression |
EXP |
1 |
267,369,497 |
267,399,705 |
RGD:6480464 |
CTD |
| G |
Eif5 |
eukaryotic translation initiation factor 5 |
|
decreases expression |
EXP |
6 |
136,311,381 |
136,318,586 |
RGD:6480464 |
CTD |
| G |
Elavl4 |
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 |
|
decreases expression |
EXP |
5 |
131,672,012 |
131,767,950 |
RGD:6480464 |
CTD |
| G |
Emd |
emerin |
|
decreases expression |
EXP |
X |
160,351,228 |
160,354,239 |
RGD:6480464 |
CTD |
| G |
Epas1 |
endothelial PAS domain protein 1 |
|
decreases expression |
EXP |
6 |
10,203,108 |
10,297,215 |
RGD:6480464 |
CTD |
| G |
Epha5 |
EPH receptor A5 |
|
decreases expression |
EXP |
14 |
25,524,170 |
25,896,798 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases activity |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
decreases activity |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Etnk1 |
ethanolamine kinase 1 |
|
decreases expression |
EXP |
4 |
181,060,600 |
181,104,724 |
RGD:6480464 |
CTD |
| G |
Faah |
fatty acid amide hydrolase |
|
decreases activity |
EXP |
5 |
136,310,965 |
136,329,817 |
RGD:6480464 |
CTD |
| G |
Fam115a |
family with sequence similarity 115, member A |
|
decreases expression |
EXP |
4 |
70,522,590 |
70,544,374 |
RGD:6480464 |
CTD |
| G |
Fam63b |
family with sequence similarity 63, member B |
|
decreases expression |
EXP |
8 |
75,078,181 |
75,134,060 |
RGD:6480464 |
CTD |
| G |
Fam81a |
family with sequence similarity 81, member A |
|
increases expression |
EXP |
8 |
74,545,022 |
74,603,938 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas cell surface death receptor |
|
increases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fbxo3 |
F-box protein 3 |
|
increases expression |
ISO |
3 |
89,446,724 |
89,479,650 |
RGD:6480464 |
CTD |
| G |
Fbxo30 |
F-box protein 30 |
|
decreases expression |
ISO |
1 |
5,975,207 |
5,991,214 |
RGD:6480464 |
CTD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
affects expression |
EXP |
18 |
31,785,480 |
31,806,452 |
RGD:6480464 |
CTD |
| G |
Fgf11 |
fibroblast growth factor 11 |
|
affects expression |
EXP |
10 |
56,619,650 |
56,622,972 |
RGD:6480464 |
CTD |
| G |
Fgf11 |
fibroblast growth factor 11 |
|
affects expression |
EXP |
10 |
56,619,650 |
56,622,972 |
RGD:6480464 |
CTD |
| G |
Fgf17 |
fibroblast growth factor 17 |
|
affects expression |
EXP |
15 |
51,038,529 |
51,044,118 |
RGD:6480464 |
CTD |
| G |
Fgf18 |
fibroblast growth factor 18 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
decreases expression |
EXP |
2 |
123,893,314 |
123,947,136 |
RGD:6480464 |
CTD |
| G |
Fgf20 |
fibroblast growth factor 20 |
|
decreases expression |
EXP |
16 |
55,386,987 |
55,393,744 |
RGD:6480464 |
CTD |
| G |
Fgf20 |
fibroblast growth factor 20 |
|
decreases expression |
EXP |
16 |
55,386,987 |
55,393,744 |
RGD:6480464 |
CTD |
| G |
Fgf22 |
fibroblast growth factor 22 |
|
decreases expression |
EXP |
7 |
11,463,299 |
11,465,189 |
RGD:6480464 |
CTD |
| G |
Fgf23 |
fibroblast growth factor 23 |
|
affects expression |
EXP |
4 |
163,468,604 |
163,476,325 |
RGD:6480464 |
CTD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
affects expression |
EXP |
15 |
37,115,068 |
37,155,652 |
RGD:6480464 |
CTD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
decreases expression |
ISO |
15 |
37,115,068 |
37,155,652 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
affects expression |
EXP |
1 |
189,482,975 |
189,589,279 |
RGD:6480464 |
CTD |
| G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
increases expression |
EXP |
17 |
15,512,144 |
15,527,348 |
RGD:6480464 |
CTD |
| G |
Fktn |
fukutin |
|
decreases expression |
EXP |
5 |
71,155,051 |
71,208,525 |
RGD:6480464 |
CTD |
| G |
Fmnl1 |
formin-like 1 |
|
increases expression |
EXP |
10 |
92,343,548 |
92,384,092 |
RGD:6480464 |
CTD |
| G |
Fntb |
farnesyltransferase, CAAX box, beta |
|
increases expression |
EXP |
6 |
99,427,967 |
99,511,373 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
decreases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
decreases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Foxn3 |
forkhead box N3 |
|
decreases expression |
EXP |
6 |
123,385,156 |
123,762,322 |
RGD:6480464 |
CTD |
| G |
Fxyd7 |
FXYD domain-containing ion transport regulator 7 |
|
increases expression |
EXP |
1 |
86,086,024 |
86,095,045 |
RGD:6480464 |
CTD |
| G |
Fzd1 |
frizzled family receptor 1 |
|
affects expression |
EXP |
4 |
25,994,423 |
25,998,821 |
RGD:6480464 |
CTD |
| G |
Fzd3 |
frizzled family receptor 3 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fzd3 |
frizzled family receptor 3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fzd5 |
frizzled family receptor 5 |
|
affects expression |
EXP |
9 |
63,386,990 |
63,388,747 |
RGD:6480464 |
CTD |
| G |
Fzd7 |
frizzled family receptor 7 |
|
increases expression |
EXP |
9 |
58,063,740 |
58,066,559 |
RGD:6480464 |
CTD |
| G |
Fzd9 |
frizzled family receptor 9 |
|
decreases expression |
EXP |
12 |
22,581,510 |
22,583,824 |
RGD:6480464 |
CTD |
| G |
Gabrb2 |
gamma-aminobutyric acid (GABA) A receptor, beta 2 |
|
decreases expression |
EXP |
10 |
27,602,085 |
27,819,145 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
multiple interactions |
ISO |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
|
decreases expression |
ISO |
17 |
19,230,896 |
19,232,641 |
RGD:6480464 |
CTD |
| G |
Gal |
galanin/GMAP prepropeptide |
|
increases expression |
EXP |
1 |
205,936,352 |
205,941,215 |
RGD:6480464 |
CTD |
| G |
Gap43 |
growth associated protein 43 |
|
affects expression |
EXP |
11 |
59,989,085 |
60,083,971 |
RGD:6480464 |
CTD |
| G |
Gas2 |
growth arrest-specific 2 |
|
increases expression |
ISO |
1 |
101,697,265 |
101,798,495 |
RGD:6480464 |
CTD |
| G |
Gbf1 |
golgi brefeldin A resistant guanine nucleotide exchange factor 1 |
|
decreases expression |
EXP |
1 |
251,373,242 |
251,501,663 |
RGD:6480464 |
CTD |
| G |
Gcm1 |
glial cells missing homolog 1 (Drosophila) |
|
increases expression |
ISO |
8 |
83,018,975 |
83,032,211 |
RGD:6480464 |
CTD |
| G |
Gda |
guanine deaminase |
|
decreases expression |
EXP |
1 |
224,579,794 |
224,655,298 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
decreases expression |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
decreases expression |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfra2 |
GDNF family receptor alpha 2 |
|
increases expression |
EXP |
15 |
51,279,770 |
51,371,053 |
RGD:6480464 |
CTD |
| G |
Ggt7 |
gamma-glutamyltransferase 7 |
|
increases expression |
EXP |
3 |
145,987,531 |
146,010,922 |
RGD:6480464 |
CTD |
| G |
Glg1 |
golgi glycoprotein 1 |
|
decreases expression |
EXP |
19 |
41,082,324 |
41,176,959 |
RGD:6480464 |
CTD |
| G |
Glra2 |
glycine receptor, alpha 2 |
|
decreases expression |
EXP |
X |
49,755,521 |
49,978,214 |
RGD:6480464 |
CTD |
| G |
Glrb |
glycine receptor, beta |
|
decreases expression |
EXP |
2 |
172,451,807 |
172,522,841 |
RGD:6480464 |
CTD |
| G |
Gmfb |
glia maturation factor, beta |
|
decreases expression |
EXP |
15 |
22,664,728 |
22,675,100 |
RGD:6480464 |
CTD |
| G |
Gna12 |
guanine nucleotide binding protein (G protein) alpha 12 |
|
affects expression |
EXP |
12 |
14,275,708 |
14,354,843 |
RGD:6480464 |
CTD |
| G |
Gna13 |
guanine nucleotide binding protein (G protein), alpha 13 |
|
affects expression |
EXP |
10 |
98,933,205 |
98,965,819 |
RGD:6480464 |
CTD |
| G |
Gna14 |
guanine nucleotide binding protein, alpha 14 |
|
increases expression |
EXP |
1 |
219,906,120 |
219,983,252 |
RGD:6480464 |
CTD |
| G |
Gnai2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
|
increases expression |
EXP |
8 |
112,861,952 |
112,882,647 |
RGD:6480464 |
CTD |
| G |
Gnai3 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 |
|
decreases expression |
EXP |
2 |
203,668,275 |
203,706,229 |
RGD:6480464 |
CTD |
| G |
Gnaq |
guanine nucleotide binding protein (G protein), q polypeptide |
|
increases expression |
ISO |
1 |
219,520,998 |
219,764,401 |
RGD:6480464 |
CTD |
| G |
Gng10 |
guanine nucleotide binding protein (G protein), gamma 10 |
|
decreases expression |
EXP |
5 |
77,083,335 |
77,090,218 |
RGD:6480464 |
CTD |
| G |
Gng12 |
guanine nucleotide binding protein (G protein), gamma 12 |
|
decreases expression |
EXP |
4 |
96,622,363 |
96,624,479 |
RGD:6480464 |
CTD |
| G |
Gnrh1 |
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
|
affects expression |
ISO |
15 |
47,303,309 |
47,307,517 |
RGD:6480464 |
CTD |
| G |
Gnrh1 |
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
|
increases secretion |
ISO |
15 |
47,303,309 |
47,307,517 |
RGD:6480464 |
CTD |
| G |
Gnrh1 |
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
|
multiple interactions |
ISO |
15 |
47,303,309 |
47,307,517 |
RGD:6480464 |
CTD |
| G |
Gnrh1 |
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
|
affects expression |
EXP |
15 |
47,303,309 |
47,307,517 |
RGD:6480464 |
CTD |
| G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble |
|
multiple interactions |
ISO |
1 |
247,324,285 |
247,347,553 |
RGD:6480464 |
CTD |
| G |
Gp9 |
glycoprotein IX (platelet) |
|
increases expression |
EXP |
4 |
121,965,797 |
121,967,132 |
RGD:6480464 |
CTD |
| G |
Gpc3 |
glypican 3 |
|
increases expression |
EXP |
X |
139,192,115 |
139,560,649 |
RGD:6480464 |
CTD |
| G |
Gpr149 |
G protein-coupled receptor 149 |
|
decreases expression |
EXP |
2 |
152,176,361 |
152,257,898 |
RGD:6480464 |
CTD |
| G |
Gpr85 |
G protein-coupled receptor 85 |
|
decreases expression |
EXP |
4 |
39,296,054 |
39,299,722 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
ISO |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
affects expression |
EXP |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gpx4 |
glutathione peroxidase 4 |
|
affects expression |
EXP |
7 |
11,162,521 |
11,165,318 |
RGD:6480464 |
CTD |
| G |
Gpx7 |
glutathione peroxidase 7 |
|
affects expression |
EXP |
5 |
129,506,986 |
129,514,830 |
RGD:6480464 |
CTD |
| G |
Grb10 |
growth factor receptor bound protein 10 |
|
decreases expression |
ISO |
14 |
92,814,797 |
92,911,442 |
RGD:6480464 |
CTD |
| G |
Grb14 |
growth factor receptor bound protein 14 |
|
decreases expression |
EXP |
3 |
46,832,380 |
46,952,670 |
RGD:6480464 |
CTD |
| G |
Gria1 |
glutamate receptor, ionotropic, AMPA 1 |
|
increases expression |
EXP |
10 |
42,613,359 |
42,616,610 |
RGD:6480464 |
CTD |
| G |
Gria2 |
glutamate receptor, ionotropic, AMPA 2 |
|
decreases expression |
EXP |
2 |
172,265,155 |
172,385,285 |
RGD:6480464 |
CTD |
| G |
Gria2 |
glutamate receptor, ionotropic, AMPA 2 |
|
decreases expression |
EXP |
2 |
172,265,155 |
172,385,285 |
RGD:6480464 |
CTD |
| G |
Gria3 |
glutamate receptor, ionotropic, AMPA 3 |
|
affects expression |
EXP |
X |
3,452,523 |
3,718,486 |
RGD:6480464 |
CTD |
| G |
Gria3 |
glutamate receptor, ionotropic, AMPA 3 |
|
increases expression |
EXP |
X |
3,452,523 |
3,718,486 |
RGD:6480464 |
CTD |
| G |
Gria3 |
glutamate receptor, ionotropic, AMPA 3 |
|
decreases expression |
EXP |
X |
3,452,523 |
3,718,486 |
RGD:6480464 |
CTD |
| G |
Gria4 |
glutamate receptor, ionotropic, AMPA 4 |
|
decreases expression |
EXP |
8 |
956,325 |
1,438,314 |
RGD:6480464 |
CTD |
| G |
Gria4 |
glutamate receptor, ionotropic, AMPA 4 |
|
decreases expression |
EXP |
8 |
956,325 |
1,438,314 |
RGD:6480464 |
CTD |
| G |
Grid1 |
glutamate receptor, ionotropic, delta 1 |
|
affects expression |
EXP |
16 |
10,473,353 |
11,202,161 |
RGD:6480464 |
CTD |
| G |
Grid2 |
glutamate receptor, ionotropic, delta 2 |
|
affects expression |
EXP |
4 |
92,642,427 |
94,054,757 |
RGD:6480464 |
CTD |
| G |
Grik2 |
glutamate receptor, ionotropic, kainate 2 |
|
decreases expression |
EXP |
20 |
53,231,473 |
53,713,131 |
RGD:6480464 |
CTD |
| G |
Grik2 |
glutamate receptor, ionotropic, kainate 2 |
|
decreases expression |
EXP |
20 |
53,231,473 |
53,713,131 |
RGD:6480464 |
CTD |
| G |
Grik3 |
glutamate receptor, ionotropic, kainate 3 |
|
affects expression |
EXP |
5 |
144,842,374 |
145,058,047 |
RGD:6480464 |
CTD |
| G |
Grik4 |
glutamate receptor, ionotropic, kainate 4 |
|
decreases expression |
EXP |
8 |
45,510,258 |
45,681,279 |
RGD:6480464 |
CTD |
| G |
Grik4 |
glutamate receptor, ionotropic, kainate 4 |
|
increases expression |
EXP |
8 |
45,510,258 |
45,681,279 |
RGD:6480464 |
CTD |
| G |
Grik5 |
glutamate receptor, ionotropic, kainate 5 |
|
increases expression |
EXP |
1 |
80,313,801 |
80,384,390 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
increases expression |
EXP |
3 |
3,453,784 |
3,480,381 |
RGD:6480464 |
CTD |
| G |
Grin2a |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
|
affects expression |
EXP |
10 |
5,588,229 |
6,004,780 |
RGD:6480464 |
CTD |
| G |
Grin2a |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
|
affects expression |
EXP |
10 |
5,588,229 |
6,004,780 |
RGD:6480464 |
CTD |
| G |
Grin2a |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
|
decreases expression |
EXP |
10 |
5,588,229 |
6,004,780 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
increases expression |
EXP |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
increases expression |
EXP |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Grin3a |
glutamate receptor, ionotropic, N-methyl-D-aspartate 3A |
|
increases expression |
EXP |
5 |
66,406,451 |
66,602,353 |
RGD:6480464 |
CTD |
| G |
Grin3a |
glutamate receptor, ionotropic, N-methyl-D-aspartate 3A |
|
decreases expression |
EXP |
5 |
66,406,451 |
66,602,353 |
RGD:6480464 |
CTD |
| G |
Grin3a |
glutamate receptor, ionotropic, N-methyl-D-aspartate 3A |
|
increases expression |
EXP |
5 |
66,406,451 |
66,602,353 |
RGD:6480464 |
CTD |
| G |
Grin3b |
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
|
decreases expression |
EXP |
7 |
11,243,973 |
11,250,311 |
RGD:6480464 |
CTD |
| G |
Grina |
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) |
|
increases expression |
EXP |
7 |
114,277,208 |
114,280,339 |
RGD:6480464 |
CTD |
| G |
Grm2 |
glutamate receptor, metabotropic 2 |
|
increases expression |
EXP |
8 |
111,837,086 |
111,850,133 |
RGD:6480464 |
CTD |
| G |
Grm4 |
glutamate receptor, metabotropic 4 |
|
increases expression |
EXP |
20 |
5,627,733 |
5,727,274 |
RGD:6480464 |
CTD |
| G |
Grm5 |
glutamate receptor, metabotropic 5 |
|
affects expression |
EXP |
1 |
143,857,225 |
144,477,419 |
RGD:6480464 |
CTD |
| G |
Grm6 |
glutamate receptor, metabotropic 6 |
|
decreases expression |
EXP |
10 |
36,421,806 |
36,436,909 |
RGD:6480464 |
CTD |
| G |
Grm7 |
glutamate receptor, metabotropic 7 |
|
increases expression |
EXP |
4 |
146,952,340 |
147,270,225 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases expression |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
affects expression |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gss |
glutathione synthetase |
|
affects expression |
EXP |
3 |
146,057,517 |
146,087,820 |
RGD:6480464 |
CTD |
| G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
increases expression |
ISO |
9 |
20,051,501 |
20,068,146 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
decreases expression |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
affects expression |
EXP |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gsta5 |
glutathione S-transferase alpha 5 |
|
decreases expression |
EXP |
8 |
83,202,554 |
83,211,997 |
RGD:6480464 |
CTD |
| G |
Gstk1 |
glutathione S-transferase kappa 1 |
|
affects expression |
EXP |
4 |
69,999,767 |
70,004,086 |
RGD:6480464 |
CTD |
| G |
Gstk1 |
glutathione S-transferase kappa 1 |
|
increases expression |
EXP |
4 |
69,999,767 |
70,004,086 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
affects expression |
EXP |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
increases expression |
EXP |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
multiple interactions |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
affects expression |
EXP |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase mu 3 |
|
decreases expression |
EXP |
2 |
203,532,363 |
203,537,135 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase mu 3 |
|
multiple interactions |
ISO |
2 |
203,532,363 |
203,537,135 |
RGD:6480464 |
CTD |
| G |
Gstm4 |
glutathione S-transferase mu 4 |
|
increases expression |
EXP |
2 |
203,605,593 |
203,610,817 |
RGD:6480464 |
CTD |
| G |
Gstm4 |
glutathione S-transferase mu 4 |
|
increases expression |
EXP |
2 |
203,605,593 |
203,610,817 |
RGD:6480464 |
CTD |
| G |
Gstm6 |
glutathione S-transferase, mu 6 |
|
increases expression |
EXP |
2 |
203,504,228 |
203,509,002 |
RGD:6480464 |
CTD |
| G |
Gsto1 |
glutathione S-transferase omega 1 |
|
increases expression |
EXP |
1 |
253,228,547 |
253,238,531 |
RGD:6480464 |
CTD |
| G |
Gsto2 |
glutathione S-transferase omega 2 |
|
decreases expression |
EXP |
1 |
253,239,392 |
253,275,110 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
increases expression |
EXP |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
increases expression |
EXP |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt2 |
glutathione S-transferase, theta 2 |
|
increases expression |
EXP |
20 |
13,221,696 |
13,225,367 |
RGD:6480464 |
CTD |
| G |
H2afv |
H2A histone family, member V |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
H3f3b |
H3 histone, family 3B |
|
decreases expression |
EXP |
10 |
106,130,320 |
106,132,544 |
RGD:6480464 |
CTD |
| G |
Hecw1 |
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 |
|
decreases expression |
ISO |
17 |
58,856,317 |
59,275,923 |
RGD:6480464 |
CTD |
| G |
Hells |
helicase, lymphoid specific |
|
decreases expression |
ISO |
1 |
243,246,843 |
243,262,459 |
RGD:6480464 |
CTD |
| G |
Hexim2 |
hexamethylene bis-acetamide inducible 2 |
|
increases expression |
ISO |
10 |
92,306,494 |
92,312,256 |
RGD:6480464 |
CTD |
| G |
Hmgb3 |
high mobility group box 3 |
|
decreases expression |
EXP |
X |
157,027,845 |
157,033,080 |
RGD:6480464 |
CTD |
| G |
Hmgn1 |
high mobility group nucleosome binding domain 1 |
|
decreases expression |
EXP |
11 |
36,429,800 |
36,435,719 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hnrnpf |
heterogeneous nuclear ribonucleoprotein F |
|
decreases expression |
EXP |
4 |
154,207,198 |
154,228,398 |
RGD:6480464 |
CTD |
| G |
Hnrpd |
heterogeneous nuclear ribonucleoprotein D |
|
decreases expression |
EXP |
14 |
10,917,674 |
10,935,989 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
increases expression |
EXP |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
decreases expression |
EXP |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock 70kDa protein 8 |
|
decreases expression |
ISO |
8 |
43,784,035 |
43,787,760 |
RGD:6480464 |
CTD |
| G |
Hspb7 |
heat shock protein family, member 7 (cardiovascular) |
|
increases expression |
EXP |
5 |
160,311,908 |
160,315,394 |
RGD:6480464 |
CTD |
| G |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
|
affects expression |
EXP |
2 |
36,434,518 |
36,435,786 |
RGD:6480464 |
CTD |
| G |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
|
increases expression |
EXP |
2 |
36,434,518 |
36,435,786 |
RGD:6480464 |
CTD |
| G |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
|
affects expression |
EXP |
2 |
36,434,518 |
36,435,786 |
RGD:6480464 |
CTD |
| G |
Htr1b |
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled |
|
affects expression |
EXP |
8 |
86,700,088 |
86,701,248 |
RGD:6480464 |
CTD |
| G |
Htr1d |
5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled |
|
increases expression |
EXP |
5 |
155,188,669 |
155,189,793 |
RGD:6480464 |
CTD |
| G |
Htr2a |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
|
increases expression |
EXP |
15 |
55,463,743 |
55,532,293 |
RGD:6480464 |
CTD |
| G |
Htr2a |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
|
increases expression |
EXP |
15 |
55,463,743 |
55,532,293 |
RGD:6480464 |
CTD |
| G |
Htr2b |
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled |
|
decreases expression |
EXP |
9 |
84,840,026 |
84,852,984 |
RGD:6480464 |
CTD |
| G |
Htr2b |
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled |
|
increases expression |
EXP |
9 |
84,840,026 |
84,852,984 |
RGD:6480464 |
CTD |
| G |
Htr2c |
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
|
decreases expression |
EXP |
X |
31,012,921 |
31,244,127 |
RGD:6480464 |
CTD |
| G |
Htr3b |
5-hydroxytryptamine (serotonin) receptor 3B, ionotropic |
|
decreases expression |
EXP |
8 |
52,198,432 |
52,228,238 |
RGD:6480464 |
CTD |
| G |
Htr3b |
5-hydroxytryptamine (serotonin) receptor 3B, ionotropic |
|
increases expression |
EXP |
8 |
52,198,432 |
52,228,238 |
RGD:6480464 |
CTD |
| G |
Htr5a |
5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled |
|
decreases expression |
EXP |
4 |
2,707,261 |
2,716,944 |
RGD:6480464 |
CTD |
| G |
Htr5a |
5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled |
|
increases expression |
EXP |
4 |
2,707,261 |
2,716,944 |
RGD:6480464 |
CTD |
| G |
Htr5b |
5-hydroxytryptamine (serotonin) receptor 5B |
|
affects expression |
EXP |
13 |
33,545,128 |
33,558,050 |
RGD:6480464 |
CTD |
| G |
Htr6 |
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Htr6 |
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Htr7 |
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled |
|
affects expression |
EXP |
1 |
240,136,279 |
240,260,620 |
RGD:6480464 |
CTD |
| G |
Htra2 |
HtrA serine peptidase 2 |
|
decreases expression |
ISO |
4 |
117,262,206 |
117,265,368 |
RGD:6480464 |
CTD |
| G |
Hydin |
Hydin, axonemal central pair apparatus protein |
|
decreases expression |
ISO |
19 |
40,183,008 |
40,531,091 |
RGD:6480464 |
CTD |
| G |
Hypk |
Huntingtin interacting protein K |
|
increases expression |
EXP |
3 |
108,262,767 |
108,264,495 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf2r |
insulin-like growth factor 2 receptor |
|
decreases expression |
EXP |
1 |
42,253,273 |
42,341,646 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
decreases expression |
EXP |
9 |
72,003,637 |
72,016,263 |
RGD:6480464 |
CTD |
| G |
Igsf11 |
immunoglobulin superfamily, member 11 |
|
decreases expression |
EXP |
11 |
63,501,592 |
63,640,441 |
RGD:6480464 |
CTD |
| G |
Il13 |
interleukin 13 |
|
increases expression |
ISO |
10 |
39,093,512 |
39,096,069 |
RGD:6480464 |
CTD |
| G |
Il17a |
interleukin 17A |
|
increases expression |
ISO |
9 |
19,454,979 |
19,458,467 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Inha |
inhibin alpha |
|
increases expression |
ISO |
9 |
74,781,223 |
74,784,124 |
RGD:6480464 |
CTD |
| G |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
|
increases expression |
EXP |
9 |
86,576,742 |
86,682,240 |
RGD:6480464 |
CTD |
| G |
Irak1bp1 |
interleukin-1 receptor-associated kinase 1 binding protein 1 |
|
decreases expression |
EXP |
8 |
87,956,612 |
87,972,991 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
decreases expression |
EXP |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Kcnh6 |
potassium voltage-gated channel, subfamily H (eag-related), member 6 |
|
increases expression |
EXP |
10 |
95,400,862 |
95,421,678 |
RGD:6480464 |
CTD |
| G |
Kdm5b |
lysine (K)-specific demethylase 5B |
|
decreases expression |
EXP |
13 |
47,502,602 |
47,576,946 |
RGD:6480464 |
CTD |
| G |
Kdm8 |
lysine (K)-specific demethylase 8 |
|
increases expression |
EXP |
1 |
184,510,173 |
184,525,036 |
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain receptor |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain receptor |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Khdrbs2 |
KH domain containing, RNA binding, signal transduction associated 2 |
|
decreases expression |
EXP |
9 |
30,918,047 |
31,404,074 |
RGD:6480464 |
CTD |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
decreases expression |
ISO |
14 |
34,906,043 |
34,984,819 |
RGD:6480464 |
CTD |
| G |
Klf13 |
Kruppel-like factor 13 |
|
decreases expression |
EXP |
1 |
118,368,164 |
118,398,938 |
RGD:6480464 |
CTD |
| G |
Klhl8 |
kelch-like family member 8 |
|
increases expression |
EXP |
14 |
6,958,124 |
7,003,630 |
RGD:6480464 |
CTD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
decreases expression |
EXP |
4 |
182,869,242 |
182,895,106 |
RGD:6480464 |
CTD |
| G |
L1cam |
L1 cell adhesion molecule |
|
decreases expression |
EXP |
X |
159,784,792 |
159,801,553 |
RGD:6480464 |
CTD |
| G |
Lamp3 |
lysosomal-associated membrane protein 3 |
|
decreases expression |
EXP |
11 |
83,449,326 |
83,476,622 |
RGD:6480464 |
CTD |
| G |
Llgl1 |
lethal giant larvae homolog 1 (Drosophila) |
|
decreases expression |
ISO |
10 |
46,845,810 |
46,859,100 |
RGD:6480464 |
CTD |
| G |
LOC100360316 |
hypothetical protein LOC100360316 |
|
decreases expression |
EXP |
16 |
33,979,260 |
33,979,532 |
RGD:6480464 |
CTD |
| G |
Lpar1 |
lysophosphatidic acid receptor 1 |
|
decreases expression |
EXP |
5 |
76,449,470 |
76,571,458 |
RGD:6480464 |
CTD |
| G |
Lrfn1 |
leucine rich repeat and fibronectin type III domain containing 1 |
|
increases expression |
EXP |
1 |
83,567,056 |
83,580,643 |
RGD:6480464 |
CTD |
| G |
Lysmd3 |
LysM, putative peptidoglycan-binding, domain containing 3 |
|
decreases expression |
EXP |
2 |
9,751,947 |
9,758,104 |
RGD:6480464 |
CTD |
| G |
Mag |
myelin-associated glycoprotein |
|
decreases expression |
EXP |
1 |
85,954,511 |
85,970,832 |
RGD:6480464 |
CTD |
| G |
Map2 |
microtubule-associated protein 2 |
|
decreases expression |
ISO |
9 |
65,174,376 |
65,256,003 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
decreases expression |
EXP |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases expression |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases expression |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases phosphorylation |
EXP |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Matr3 |
matrin 3 |
|
decreases expression |
EXP |
18 |
28,171,639 |
28,215,659 |
RGD:6480464 |
CTD |
| G |
Mcrs1 |
microspherule protein 1 |
|
increases expression |
EXP |
7 |
138,002,551 |
138,011,365 |
RGD:6480464 |
CTD |
| G |
Med1 |
mediator complex subunit 1 |
|
decreases expression |
ISO |
10 |
86,917,525 |
86,959,080 |
RGD:6480464 |
CTD |
| G |
Med1 |
mediator complex subunit 1 |
|
decreases expression |
EXP |
10 |
86,917,525 |
86,959,080 |
RGD:6480464 |
CTD |
| G |
Mef2c |
myocyte enhancer factor 2C |
|
increases expression |
ISO |
2 |
12,331,078 |
12,346,520 |
RGD:6480464 |
CTD |
| G |
Meis2 |
Meis homeobox 2 |
|
decreases expression |
EXP |
3 |
101,915,966 |
102,117,215 |
RGD:6480464 |
CTD |
| G |
Men1 |
multiple endocrine neoplasia I |
|
increases expression |
EXP |
1 |
209,114,987 |
209,120,837 |
RGD:6480464 |
CTD |
| G |
Mex3c |
mex-3 homolog C (C. elegans) |
|
decreases expression |
EXP |
18 |
70,355,267 |
70,376,424 |
RGD:6480464 |
CTD |
| G |
Mgst2 |
microsomal glutathione S-transferase 2 |
|
decreases expression |
EXP |
2 |
140,546,939 |
140,568,616 |
RGD:6480464 |
CTD |
| G |
Mgst2 |
microsomal glutathione S-transferase 2 |
|
increases expression |
EXP |
2 |
140,546,939 |
140,568,616 |
RGD:6480464 |
CTD |
| G |
Mgst3 |
microsomal glutathione S-transferase 3 |
|
decreases expression |
EXP |
13 |
83,038,049 |
83,058,802 |
RGD:6480464 |
CTD |
| G |
Mlec |
malectin |
|
increases expression |
EXP |
12 |
42,729,870 |
42,740,346 |
RGD:6480464 |
CTD |
| G |
Mobp |
myelin-associated oligodendrocyte basic protein |
|
decreases expression |
EXP |
8 |
125,118,618 |
125,144,099 |
RGD:6480464 |
CTD |
| G |
Mog |
myelin oligodendrocyte glycoprotein |
|
affects expression |
EXP |
20 |
1,601,731 |
1,611,963 |
RGD:6480464 |
CTD |
| G |
Mpdu1 |
mannose-P-dolichol utilization defect 1 |
|
increases expression |
EXP |
10 |
56,474,179 |
56,480,188 |
RGD:6480464 |
CTD |
| G |
Mpz |
myelin protein zero |
|
decreases expression |
EXP |
13 |
87,040,479 |
87,045,378 |
RGD:6480464 |
CTD |
| G |
Mre11a |
MRE11 meiotic recombination 11 homolog A (S. cerevisiae) |
|
decreases expression |
ISO |
8 |
11,588,409 |
11,632,483 |
RGD:6480464 |
CTD |
| G |
Mrfap1 |
Morf4 family associated protein 1 |
|
decreases expression |
EXP |
14 |
79,587,301 |
79,589,078 |
RGD:6480464 |
CTD |
| G |
Mrpl51 |
mitochondrial ribosomal protein L51 |
|
increases expression |
EXP |
4 |
161,311,611 |
161,314,569 |
RGD:6480464 |
CTD |
| G |
Mtdh |
metadherin |
|
decreases expression |
EXP |
7 |
69,527,182 |
69,583,015 |
RGD:6480464 |
CTD |
| G |
Mtfp1 |
mitochondrial fission process 1 |
|
increases expression |
EXP |
14 |
84,723,113 |
84,726,953 |
RGD:6480464 |
CTD |
| G |
Mtmr9 |
myotubularin related protein 9 |
|
decreases expression |
EXP |
15 |
42,787,644 |
42,809,678 |
RGD:6480464 |
CTD |
| G |
Murc |
muscle-related coiled-coil protein |
|
decreases expression |
EXP |
5 |
65,357,777 |
65,365,621 |
RGD:6480464 |
CTD |
| G |
Mycbp2 |
MYC binding protein 2, E3 ubiquitin protein ligase |
|
decreases expression |
EXP |
15 |
87,124,558 |
87,364,839 |
RGD:6480464 |
CTD |
| G |
Myo5a |
myosin VA |
|
increases expression |
ISO |
8 |
79,909,224 |
80,027,290 |
RGD:6480464 |
CTD |
| G |
Nab1 |
Ngfi-A binding protein 1 |
|
decreases expression |
EXP |
9 |
46,084,090 |
46,124,259 |
RGD:6480464 |
CTD |
| G |
Nanog |
Nanog homeobox |
|
decreases expression |
ISO |
4 |
159,190,786 |
159,198,160 |
RGD:6480464 |
CTD |
| G |
Ncam1 |
neural cell adhesion molecule 1 |
|
decreases expression |
EXP |
8 |
52,822,350 |
53,120,572 |
RGD:6480464 |
CTD |
| G |
Nceh1 |
neutral cholesterol ester hydrolase 1 |
|
decreases activity |
EXP |
2 |
113,069,474 |
113,128,268 |
RGD:6480464 |
CTD |
| G |
Nceh1 |
neutral cholesterol ester hydrolase 1 |
|
multiple interactions |
ISO |
2 |
113,069,474 |
113,128,268 |
RGD:6480464 |
CTD |
| G |
Nceh1 |
neutral cholesterol ester hydrolase 1 |
|
increases response to substance |
ISO |
2 |
113,069,474 |
113,128,268 |
RGD:6480464 |
CTD |
| G |
Nceh1 |
neutral cholesterol ester hydrolase 1 |
|
decreases activity |
ISO |
2 |
113,069,474 |
113,128,268 |
RGD:6480464 |
CTD |
| G |
Ncoa4 |
nuclear receptor coactivator 4 |
|
decreases expression |
ISO |
16 |
7,642,116 |
7,662,460 |
RGD:6480464 |
CTD |
| G |
Ndst1 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
|
decreases expression |
ISO |
18 |
56,638,891 |
56,677,831 |
RGD:6480464 |
CTD |
| G |
Ndufb3 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 3 |
|
decreases expression |
EXP |
9 |
57,252,769 |
57,262,981 |
RGD:6480464 |
CTD |
| G |
Nefl |
neurofilament, light polypeptide |
|
increases expression |
EXP |
15 |
47,636,303 |
47,640,176 |
RGD:6480464 |
CTD |
| G |
Nefm |
neurofilament, medium polypeptide |
|
increases expression |
EXP |
15 |
47,698,371 |
47,703,350 |
RGD:6480464 |
CTD |
| G |
Negr1 |
neuronal growth regulator 1 |
|
decreases expression |
EXP |
2 |
254,666,633 |
255,426,378 |
RGD:6480464 |
CTD |
| G |
Nes |
nestin |
|
increases expression |
ISO |
2 |
180,051,907 |
180,060,947 |
RGD:6480464 |
CTD |
| G |
Neurod1 |
neuronal differentiation 1 |
|
decreases expression |
EXP |
3 |
62,224,633 |
62,227,936 |
RGD:6480464 |
CTD |
| G |
Nfat5 |
nuclear factor of activated T-cells 5, tonicity-responsive |
|
decreases expression |
EXP |
19 |
37,154,326 |
37,242,191 |
RGD:6480464 |
CTD |
| G |
Nfib |
nuclear factor I/B |
|
decreases expression |
EXP |
5 |
101,184,253 |
101,409,907 |
RGD:6480464 |
CTD |
| G |
Nfix |
nuclear factor I/X (CCAAT-binding transcription factor) |
|
decreases expression |
EXP |
19 |
25,018,352 |
25,111,367 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
affects expression |
EXP |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
multiple interactions |
ISO |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
decreases expression |
EXP |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Ninj1 |
ninjurin 1 |
|
increases expression |
EXP |
17 |
21,410,701 |
21,419,472 |
RGD:6480464 |
CTD |
| G |
Nip30 |
NEFA-interacting nuclear protein NIP30 |
|
increases expression |
ISO |
19 |
10,843,499 |
10,873,030 |
RGD:6480464 |
CTD |
| G |
Notch1 |
notch 1 |
|
decreases expression |
EXP |
3 |
4,631,797 |
4,677,640 |
RGD:6480464 |
CTD |
| G |
Npy |
neuropeptide Y |
|
increases expression |
EXP |
4 |
78,038,013 |
78,045,187 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
increases activity |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
multiple interactions |
ISO |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
increases expression |
ISO |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
increases expression |
ISO |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
decreases expression |
EXP |
7 |
140,012,807 |
140,020,590 |
RGD:6480464 |
CTD |
| G |
Nras |
neuroblastoma ras oncogene |
|
decreases expression |
EXP |
2 |
198,292,650 |
198,300,286 |
RGD:6480464 |
CTD |
| G |
Nrcam |
neuronal cell adhesion molecule |
|
decreases expression |
EXP |
6 |
63,717,460 |
64,015,522 |
RGD:6480464 |
CTD |
| G |
Nrcam |
neuronal cell adhesion molecule |
|
decreases expression |
ISO |
6 |
63,717,460 |
64,015,522 |
RGD:6480464 |
CTD |
| G |
Nrcam |
neuronal cell adhesion molecule |
|
decreases expression |
EXP |
6 |
63,717,460 |
64,015,522 |
RGD:6480464 |
CTD |
| G |
Ntf3 |
neurotrophin 3 |
|
decreases expression |
EXP |
4 |
162,435,781 |
162,506,961 |
RGD:6480464 |
CTD |
| G |
Ntf4 |
neurotrophin 4 |
|
increases expression |
EXP |
1 |
95,885,577 |
95,888,408 |
RGD:6480464 |
CTD |
| G |
Ntrk1 |
neurotrophic tyrosine kinase, receptor, type 1 |
|
increases expression |
EXP |
2 |
179,838,740 |
179,855,545 |
RGD:6480464 |
CTD |
| G |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
|
decreases expression |
EXP |
17 |
11,494,463 |
11,811,654 |
RGD:6480464 |
CTD |
| G |
Ntrk3 |
neurotrophic tyrosine kinase, receptor, type 3 |
|
decreases expression |
EXP |
1 |
133,925,530 |
134,302,139 |
RGD:6480464 |
CTD |
| G |
Nts |
neurotensin |
|
increases expression |
EXP |
7 |
40,474,654 |
40,484,058 |
RGD:6480464 |
CTD |
| G |
Nudc |
nuclear distribution C homolog (A. nidulans) |
|
increases expression |
ISO |
5 |
151,535,900 |
151,550,041 |
RGD:6480464 |
CTD |
| G |
Oprd1 |
opioid receptor, delta 1 |
|
increases expression |
EXP |
5 |
150,979,252 |
151,014,066 |
RGD:6480464 |
CTD |
| G |
Otub1 |
OTU domain, ubiquitin aldehyde binding 1 |
|
increases expression |
EXP |
1 |
209,871,581 |
209,879,518 |
RGD:6480464 |
CTD |
| G |
Otud7b |
OTU domain containing 7B |
|
increases expression |
ISO |
2 |
190,905,522 |
190,964,454 |
RGD:6480464 |
CTD |
| G |
Oxct1 |
3-oxoacid CoA transferase 1 |
|
decreases expression |
EXP |
2 |
53,189,358 |
53,217,848 |
RGD:6480464 |
CTD |
| G |
Oxt |
oxytocin/neurophysin 1 prepropeptide |
|
increases expression |
ISO |
3 |
118,194,219 |
118,195,056 |
RGD:6480464 |
CTD |
| G |
Oxtr |
oxytocin receptor |
|
increases expression |
EXP |
4 |
148,314,089 |
148,326,797 |
RGD:6480464 |
CTD |
| G |
Pafah1b1 |
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 |
|
decreases expression |
ISO |
10 |
61,955,348 |
62,037,871 |
RGD:6480464 |
CTD |
| G |
Pak3 |
p21 protein (Cdc42/Rac)-activated kinase 3 |
|
decreases expression |
EXP |
X |
34,734,814 |
34,842,093 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
EXP |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pcdh18 |
protocadherin 18 |
|
decreases expression |
ISO |
2 |
138,615,496 |
138,629,181 |
RGD:6480464 |
CTD |
| G |
Pcdha6 |
protocadherin alpha 6 |
|
decreases expression |
EXP |
18 |
29,697,876 |
29,928,030 |
RGD:6480464 |
CTD |
| G |
Pclo |
piccolo (presynaptic cytomatrix protein) |
|
decreases expression |
EXP |
4 |
15,911,051 |
16,269,090 |
RGD:6480464 |
CTD |
| G |
Pcp4l1 |
Purkinje cell protein 4-like 1 |
|
decreases expression |
EXP |
13 |
87,059,476 |
87,083,085 |
RGD:6480464 |
CTD |
| G |
Pcsk2 |
proprotein convertase subtilisin/kexin type 2 |
|
increases expression |
ISO |
3 |
131,925,648 |
132,256,178 |
RGD:6480464 |
CTD |
| G |
Pdcd4 |
programmed cell death 4 |
|
increases expression |
ISO |
1 |
260,183,648 |
260,202,032 |
RGD:6480464 |
CTD |
| G |
Pde1c |
phosphodiesterase 1C |
|
affects expression |
EXP |
4 |
84,936,642 |
85,448,339 |
RGD:6480464 |
CTD |
| G |
Pde3b |
phosphodiesterase 3B, cGMP-inhibited |
|
decreases expression |
EXP |
1 |
172,409,282 |
172,577,108 |
RGD:6480464 |
CTD |
| G |
Pde5a |
phosphodiesterase 5A, cGMP-specific |
|
decreases expression |
EXP |
2 |
219,410,394 |
219,550,910 |
RGD:6480464 |
CTD |
| G |
Pde8a |
phosphodiesterase 8A |
|
increases expression |
EXP |
1 |
137,415,852 |
137,544,337 |
RGD:6480464 |
CTD |
| G |
Pds5b |
PDS5, regulator of cohesion maintenance, homolog B (S. cerevisiae) |
|
decreases expression |
ISO |
12 |
4,038,430 |
4,128,352 |
RGD:6480464 |
CTD |
| G |
Pdyn |
prodynorphin |
|
decreases expression |
EXP |
3 |
117,291,025 |
117,303,367 |
RGD:6480464 |
CTD |
| G |
Penk |
proenkephalin |
|
increases expression |
EXP |
5 |
17,509,323 |
17,514,265 |
RGD:6480464 |
CTD |
| G |
Pgls |
6-phosphogluconolactonase |
|
decreases expression |
EXP |
16 |
18,791,241 |
18,796,727 |
RGD:6480464 |
CTD |
| G |
Phip |
pleckstrin homology domain interacting protein |
|
decreases expression |
ISO |
8 |
88,009,896 |
88,060,553 |
RGD:6480464 |
CTD |
| G |
Pigc |
phosphatidylinositol glycan anchor biosynthesis, class C |
|
decreases expression |
EXP |
13 |
77,664,442 |
77,666,797 |
RGD:6480464 |
CTD |
| G |
Pip4k2a |
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
|
decreases expression |
EXP |
17 |
92,950,531 |
93,111,944 |
RGD:6480464 |
CTD |
| G |
Pja2 |
praja ring finger 2, E3 ubiquitin protein ligase |
|
decreases expression |
EXP |
9 |
103,002,778 |
103,054,007 |
RGD:6480464 |
CTD |
| G |
Pkib |
protein kinase (cAMP-dependent, catalytic) inhibitor beta |
|
increases expression |
EXP |
20 |
36,655,506 |
36,750,474 |
RGD:6480464 |
CTD |
| G |
Pnpla6 |
patatin-like phospholipase domain containing 6 |
|
increases expression |
ISO |
12 |
2,610,552 |
2,638,753 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
increases response to substance |
ISO |
4 |
29,936,314 |
29,964,821 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
affects metabolic processing |
ISO |
4 |
29,936,314 |
29,964,821 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
increases hydrolysis |
ISO |
4 |
29,936,314 |
29,964,821 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
affects response to substance |
ISO |
4 |
29,936,314 |
29,964,821 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
increases response to substance |
ISO |
4 |
29,936,314 |
29,964,821 |
RGD:6480464 |
CTD |
| G |
Pou5f1 |
POU class 5 homeobox 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ppp1r2 |
protein phosphatase 1, regulatory (inhibitor) subunit 2 |
|
decreases expression |
EXP |
11 |
71,319,294 |
71,342,716 |
RGD:6480464 |
CTD |
| G |
Ppp3ca |
protein phosphatase 3, catalytic subunit, alpha isozyme |
|
increases expression |
ISO |
2 |
234,130,176 |
234,409,232 |
RGD:6480464 |
CTD |
| G |
Ppp4r4 |
protein phosphatase 4, regulatory subunit 4 |
|
increases expression |
EXP |
6 |
127,800,835 |
127,884,950 |
RGD:6480464 |
CTD |
| G |
Prkaa1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit |
|
increases expression |
EXP |
2 |
54,327,821 |
54,360,462 |
RGD:6480464 |
CTD |
| G |
Prkab2 |
protein kinase, AMP-activated, beta 2 non-catalytic subunit |
|
increases expression |
EXP |
2 |
192,498,430 |
192,510,624 |
RGD:6480464 |
CTD |
| G |
Prkag2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
|
affects expression |
EXP |
4 |
5,620,992 |
5,667,438 |
RGD:6480464 |
CTD |
| G |
Prkar2b |
protein kinase, cAMP dependent regulatory, type II beta |
|
affects expression |
EXP |
6 |
50,234,979 |
50,325,298 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
decreases expression |
EXP |
10 |
97,367,196 |
97,638,910 |
RGD:6480464 |
CTD |
| G |
Prkcb |
protein kinase C, beta |
|
increases expression |
EXP |
1 |
181,117,512 |
181,459,856 |
RGD:6480464 |
CTD |
| G |
Prkcdbp |
protein kinase C, delta binding protein |
|
increases expression |
EXP |
1 |
163,212,922 |
163,214,511 |
RGD:6480464 |
CTD |
| G |
Prkce |
protein kinase C, epsilon |
|
decreases expression |
EXP |
6 |
9,631,234 |
10,097,311 |
RGD:6480464 |
CTD |
| G |
Prkce |
protein kinase C, epsilon |
|
increases expression |
EXP |
6 |
9,631,234 |
10,097,311 |
RGD:6480464 |
CTD |
| G |
Prkch |
protein kinase C, eta |
|
decreases expression |
EXP |
6 |
96,069,354 |
96,281,790 |
RGD:6480464 |
CTD |
| G |
Prkch |
protein kinase C, eta |
|
decreases expression |
EXP |
6 |
96,069,354 |
96,281,790 |
RGD:6480464 |
CTD |
| G |
Prkci |
protein kinase C, iota |
|
decreases expression |
EXP |
2 |
116,739,625 |
116,801,084 |
RGD:6480464 |
CTD |
| G |
Prkd1 |
protein kinase D1 |
|
decreases expression |
EXP |
6 |
70,364,135 |
70,682,006 |
RGD:6480464 |
CTD |
| G |
Prkd3 |
protein kinase D3 |
|
affects expression |
EXP |
6 |
1,727,315 |
1,796,290 |
RGD:6480464 |
CTD |
| G |
Prkd3 |
protein kinase D3 |
|
increases expression |
EXP |
6 |
1,727,315 |
1,796,290 |
RGD:6480464 |
CTD |
| G |
Ptk2 |
protein tyrosine kinase 2 |
|
increases expression |
EXP |
7 |
110,933,298 |
111,084,554 |
RGD:6480464 |
CTD |
| G |
Ptprf |
protein tyrosine phosphatase, receptor type, F |
|
decreases expression |
EXP |
5 |
138,671,725 |
138,739,002 |
RGD:6480464 |
CTD |
| G |
Pxn |
paxillin |
|
increases expression |
EXP |
12 |
42,322,193 |
42,370,507 |
RGD:6480464 |
CTD |
| G |
Rab14 |
RAB14, member RAS oncogene family |
|
decreases expression |
EXP |
3 |
14,245,693 |
14,255,984 |
RGD:6480464 |
CTD |
| G |
Rasgrp1 |
RAS guanyl releasing protein 1 (calcium and DAG-regulated) |
|
decreases expression |
EXP |
3 |
103,371,879 |
103,433,010 |
RGD:6480464 |
CTD |
| G |
Rbfox2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
|
decreases expression |
EXP |
7 |
115,143,721 |
115,384,534 |
RGD:6480464 |
CTD |
| G |
Rbl1 |
retinoblastoma-like 1 (p107) |
|
decreases expression |
ISO |
3 |
147,734,622 |
147,796,630 |
RGD:6480464 |
CTD |
| G |
Rbm39 |
RNA binding motif protein 39 |
|
decreases expression |
EXP |
3 |
146,555,202 |
146,587,650 |
RGD:6480464 |
CTD |
| G |
Rbm4 |
RNA binding motif protein 4 |
|
increases expression |
EXP |
1 |
207,394,470 |
207,403,393 |
RGD:6480464 |
CTD |
| G |
Rbm5 |
RNA binding motif protein 5 |
|
decreases expression |
ISO |
8 |
112,995,731 |
113,024,356 |
RGD:6480464 |
CTD |
| G |
Reck |
reversion-inducing-cysteine-rich protein with kazal motifs |
|
increases expression |
ISO |
5 |
60,341,438 |
60,407,710 |
RGD:6480464 |
CTD |
| G |
Reep5 |
receptor accessory protein 5 |
|
decreases expression |
EXP |
18 |
26,813,889 |
26,845,178 |
RGD:6480464 |
CTD |
| G |
Reln |
reelin |
|
decreases expression |
EXP |
4 |
8,150,873 |
8,609,141 |
RGD:6480464 |
CTD |
| G |
Ret |
ret proto-oncogene |
|
decreases expression |
ISO |
4 |
154,448,179 |
154,491,103 |
RGD:6480464 |
CTD |
| G |
RGD1565472 |
similar to RIKEN cDNA 2310003P10 |
|
increases expression |
EXP |
11 |
38,344,346 |
38,543,839 |
RGD:6480464 |
CTD |
| G |
RGD1565959 |
RGD1565959 |
|
increases expression |
EXP |
9 |
8,282,628 |
8,295,293 |
RGD:6480464 |
CTD |
| G |
Rgs2 |
regulator of G-protein signaling 2 |
|
decreases expression |
ISO |
13 |
57,891,849 |
57,894,452 |
RGD:6480464 |
CTD |
| G |
Rims3 |
regulating synaptic membrane exocytosis 3 |
|
increases expression |
EXP |
5 |
141,449,059 |
141,477,301 |
RGD:6480464 |
CTD |
| G |
Rnase4 |
ribonuclease, RNase A family 4 |
|
decreases expression |
EXP |
15 |
27,073,756 |
27,090,441 |
RGD:6480464 |
CTD |
| G |
Rnd1 |
Rho family GTPase 1 |
|
decreases expression |
ISO |
7 |
137,418,519 |
137,425,590 |
RGD:6480464 |
CTD |
| G |
Rnf112 |
ring finger protein 112 |
|
increases expression |
EXP |
10 |
47,599,958 |
47,605,503 |
RGD:6480464 |
CTD |
| G |
Rnf128 |
ring finger protein 128, E3 ubiquitin protein ligase |
|
decreases expression |
ISO |
X |
127,309,082 |
127,367,165 |
RGD:6480464 |
CTD |
| G |
Rnf144b |
ring finger protein 144B |
|
increases expression |
ISO |
17 |
23,483,622 |
23,615,443 |
RGD:6480464 |
CTD |
| G |
Rpl27 |
ribosomal protein L27 |
|
increases expression |
EXP |
10 |
90,469,811 |
90,473,510 |
RGD:6480464 |
CTD |
| G |
Rtn4 |
reticulon 4 |
|
decreases expression |
ISO |
14 |
110,725,089 |
110,772,578 |
RGD:6480464 |
CTD |
| G |
Rtn4rl2 |
reticulon 4 receptor-like 2 |
|
increases expression |
ISO |
3 |
68,098,435 |
68,113,874 |
RGD:6480464 |
CTD |
| G |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
|
increases expression |
EXP |
2 |
211,851,304 |
211,855,511 |
RGD:6480464 |
CTD |
| G |
Sc5d |
sterol-C5-desaturase |
|
decreases expression |
EXP |
8 |
45,229,976 |
45,238,924 |
RGD:6480464 |
CTD |
| G |
Scd |
stearoyl-CoA desaturase (delta-9-desaturase) |
|
increases expression |
EXP |
1 |
249,358,105 |
249,371,164 |
RGD:6480464 |
CTD |
| G |
Scg3 |
secretogranin III |
|
increases expression |
EXP |
8 |
80,467,921 |
80,514,192 |
RGD:6480464 |
CTD |
| G |
Scp2 |
sterol carrier protein 2 |
|
increases expression |
EXP |
5 |
129,152,836 |
129,230,401 |
RGD:6480464 |
CTD |
| G |
Sec14l2 |
SEC14-like 2 (S. cerevisiae) |
|
increases expression |
EXP |
14 |
84,728,484 |
84,748,418 |
RGD:6480464 |
CTD |
| G |
Sec63 |
SEC63 homolog (S. cerevisiae) |
|
decreases expression |
EXP |
20 |
46,669,125 |
46,738,077 |
RGD:6480464 |
CTD |
| G |
Sema3b |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B |
|
decreases expression |
ISO |
8 |
112,845,709 |
112,852,565 |
RGD:6480464 |
CTD |
| G |
Sema4b |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
|
increases expression |
ISO |
1 |
136,001,219 |
136,031,302 |
RGD:6480464 |
CTD |
| G |
Sema4f |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4F |
|
decreases expression |
EXP |
4 |
117,104,658 |
117,130,965 |
RGD:6480464 |
CTD |
| G |
Sema4g |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G |
|
increases expression |
ISO |
1 |
250,057,504 |
250,068,990 |
RGD:6480464 |
CTD |
| G |
Sema7a |
semaphorin 7A, GPI membrane anchor |
|
decreases expression |
ISO |
8 |
61,717,449 |
61,739,529 |
RGD:6480464 |
CTD |
| G |
Senp2 |
Sumo1/sentrin/SMT3 specific peptidase 2 |
|
increases expression |
ISO |
11 |
81,225,720 |
81,259,934 |
RGD:6480464 |
CTD |
| G |
Senp7 |
SUMO1/sentrin specific peptidase 7 |
|
decreases expression |
ISO |
11 |
45,390,458 |
45,539,624 |
RGD:6480464 |
CTD |
| G |
Sepp1 |
selenoprotein P, plasma, 1 |
|
increases expression |
ISO |
2 |
52,451,883 |
52,462,263 |
RGD:6480464 |
CTD |
| G |
Sf3b1 |
splicing factor 3b, subunit 1 |
|
decreases expression |
EXP |
9 |
53,796,176 |
53,837,297 |
RGD:6480464 |
CTD |
| G |
Sh3bgrl |
SH3 domain binding glutamic acid-rich protein like |
|
decreases expression |
EXP |
X |
97,453,828 |
97,559,778 |
RGD:6480464 |
CTD |
| G |
Sh3bp4 |
SH3-domain binding protein 4 |
|
decreases expression |
EXP |
9 |
88,227,341 |
88,243,397 |
RGD:6480464 |
CTD |
| G |
Sh3kbp1 |
SH3-domain kinase binding protein 1 |
|
decreases expression |
EXP |
X |
56,075,533 |
56,422,980 |
RGD:6480464 |
CTD |
| G |
Shkbp1 |
Sh3kbp1 binding protein 1 |
|
increases expression |
EXP |
1 |
82,422,792 |
82,436,208 |
RGD:6480464 |
CTD |
| G |
Shprh |
SNF2 histone linker PHD RING helicase, E3 ubiquitin protein ligase |
|
decreases expression |
ISO |
1 |
5,846,062 |
5,922,176 |
RGD:6480464 |
CTD |
| G |
Sim2 |
single-minded homolog 2 (Drosophila) |
|
increases expression |
EXP |
11 |
34,335,645 |
34,376,925 |
RGD:6480464 |
CTD |
| G |
Skp2 |
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase |
|
decreases expression |
ISO |
2 |
58,769,164 |
58,797,229 |
RGD:6480464 |
CTD |
| G |
Slc12a2 |
solute carrier family 12 (sodium/potassium/chloride transporters), member 2 |
|
decreases expression |
EXP |
18 |
53,673,215 |
53,741,352 |
RGD:6480464 |
CTD |
| G |
Slc17a8 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8 |
|
multiple interactions |
ISO |
7 |
26,361,488 |
26,413,820 |
RGD:6480464 |
CTD |
| G |
Slc17a8 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8 |
|
decreases expression |
EXP |
7 |
26,361,488 |
26,413,820 |
RGD:6480464 |
CTD |
| G |
Slc18a1 |
solute carrier family 18 (vesicular monoamine), member 1 |
|
affects expression |
EXP |
16 |
22,356,304 |
22,389,827 |
RGD:6480464 |
CTD |
| G |
Slc18a1 |
solute carrier family 18 (vesicular monoamine), member 1 |
|
affects expression |
EXP |
16 |
22,356,304 |
22,389,827 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
affects expression |
EXP |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
increases expression |
EXP |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
affects expression |
EXP |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc18a3 |
solute carrier family 18 (vesicular acetylcholine), member 3 |
|
increases expression |
EXP |
16 |
7,969,738 |
7,972,599 |
RGD:6480464 |
CTD |
| G |
Slc1a1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
|
multiple interactions |
ISO |
1 |
232,469,746 |
232,549,584 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
decreases expression |
EXP |
3 |
87,870,558 |
87,992,401 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
multiple interactions |
ISO |
3 |
87,870,558 |
87,992,401 |
RGD:6480464 |
CTD |
| G |
Slc1a3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
|
increases expression |
EXP |
2 |
58,270,236 |
58,347,613 |
RGD:6480464 |
CTD |
| G |
Slc1a3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
|
multiple interactions |
ISO |
2 |
58,270,236 |
58,347,613 |
RGD:6480464 |
CTD |
| G |
Slc1a4 |
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
|
increases expression |
EXP |
14 |
101,123,740 |
101,153,790 |
RGD:6480464 |
CTD |
| G |
Slc1a4 |
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
|
multiple interactions |
ISO |
14 |
101,123,740 |
101,153,790 |
RGD:6480464 |
CTD |
| G |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
|
increases expression |
EXP |
1 |
77,111,082 |
77,125,166 |
RGD:6480464 |
CTD |
| G |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
|
multiple interactions |
ISO |
1 |
77,111,082 |
77,125,166 |
RGD:6480464 |
CTD |
| G |
Slc1a6 |
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 |
|
multiple interactions |
ISO |
7 |
12,393,284 |
12,419,893 |
RGD:6480464 |
CTD |
| G |
Slc1a7 |
solute carrier family 1 (glutamate transporter), member 7 |
|
multiple interactions |
ISO |
5 |
129,075,111 |
129,118,812 |
RGD:6480464 |
CTD |
| G |
Slc24a2 |
solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 |
|
decreases expression |
EXP |
5 |
106,295,254 |
106,537,714 |
RGD:6480464 |
CTD |
| G |
Slc2a13 |
solute carrier family 2 (facilitated glucose transporter), member 13 |
|
decreases expression |
EXP |
7 |
129,682,782 |
130,005,752 |
RGD:6480464 |
CTD |
| G |
Slc2a8 |
solute carrier family 2, (facilitated glucose transporter) member 8 |
|
increases expression |
ISO |
3 |
11,962,570 |
11,972,115 |
RGD:6480464 |
CTD |
| G |
Slc30a3 |
solute carrier family 30 (zinc transporter), member 3 |
|
increases expression |
EXP |
6 |
25,257,765 |
25,264,794 |
RGD:6480464 |
CTD |
| G |
Slc38a1 |
solute carrier family 38, member 1 |
|
decreases expression |
EXP |
7 |
135,252,257 |
135,316,256 |
RGD:6480464 |
CTD |
| G |
Slc5a7 |
solute carrier family 5 (choline transporter), member 7 |
|
decreases expression |
EXP |
9 |
133,838 |
165,943 |
RGD:6480464 |
CTD |
| G |
Slc6a2 |
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
|
affects expression |
EXP |
19 |
15,098,281 |
15,139,898 |
RGD:6480464 |
CTD |
| G |
Slc6a2 |
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
|
increases expression |
EXP |
19 |
15,098,281 |
15,139,898 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
affects expression |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
decreases expression |
EXP |
10 |
67,134,790 |
67,155,891 |
RGD:6480464 |
CTD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
decreases expression |
EXP |
10 |
67,134,790 |
67,155,891 |
RGD:6480464 |
CTD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
increases expression |
EXP |
10 |
67,134,790 |
67,155,891 |
RGD:6480464 |
CTD |
| G |
Slc6a8 |
solute carrier family 6 (neurotransmitter transporter, creatine), member 8 |
|
decreases expression |
EXP |
X |
159,570,789 |
159,580,093 |
RGD:6480464 |
CTD |
| G |
Slc6a8 |
solute carrier family 6 (neurotransmitter transporter, creatine), member 8 |
|
increases expression |
EXP |
X |
159,570,789 |
159,580,093 |
RGD:6480464 |
CTD |
| G |
Slc7a11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
decreases expression |
EXP |
2 |
139,241,142 |
139,317,101 |
RGD:6480464 |
CTD |
| G |
Slc7a11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
multiple interactions |
ISO |
2 |
139,241,142 |
139,317,101 |
RGD:6480464 |
CTD |
| G |
Slitrk1 |
SLIT and NTRK-like family, member 1 |
|
decreases expression |
ISO |
15 |
93,205,850 |
93,209,888 |
RGD:6480464 |
CTD |
| G |
Smarcd1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 |
|
decreases expression |
EXP |
7 |
138,444,520 |
138,455,060 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
increases expression |
EXP |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases expression |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases expression |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
decreases expression |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
decreases expression |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod3 |
superoxide dismutase 3, extracellular |
|
decreases expression |
EXP |
14 |
63,381,447 |
63,387,180 |
RGD:6480464 |
CTD |
| G |
Sox18 |
SRY (sex determining region Y)-box 18 |
|
increases expression |
EXP |
3 |
170,820,460 |
170,822,262 |
RGD:6480464 |
CTD |
| G |
Sp1 |
Sp1 transcription factor |
|
affects expression |
EXP |
7 |
141,164,180 |
141,194,509 |
RGD:6480464 |
CTD |
| G |
Spag5 |
sperm associated antigen 5 |
|
decreases expression |
ISO |
10 |
64,313,146 |
64,330,975 |
RGD:6480464 |
CTD |
| G |
Sparc |
secreted protein, acidic, cysteine-rich (osteonectin) |
|
decreases expression |
ISO |
10 |
40,809,730 |
40,831,481 |
RGD:6480464 |
CTD |
| G |
Spdya |
speedy/RINGO cell cycle regulator family member A |
|
increases expression |
ISO |
6 |
24,016,267 |
24,060,920 |
RGD:6480464 |
CTD |
| G |
Sptbn1 |
spectrin, beta, non-erythrocytic 1 |
|
decreases expression |
EXP |
14 |
111,076,741 |
111,246,286 |
RGD:6480464 |
CTD |
| G |
Srf |
serum response factor (c-fos serum response element-binding transcription factor) |
|
increases expression |
EXP |
9 |
9,788,378 |
9,797,639 |
RGD:6480464 |
CTD |
| G |
Srf |
serum response factor (c-fos serum response element-binding transcription factor) |
|
decreases expression |
EXP |
9 |
9,788,378 |
9,797,639 |
RGD:6480464 |
CTD |
| G |
Srpk2 |
SRSF protein kinase 2 |
|
decreases expression |
EXP |
4 |
6,918,521 |
7,039,871 |
RGD:6480464 |
CTD |
| G |
Sst |
somatostatin |
|
decreases expression |
EXP |
11 |
79,125,031 |
79,126,216 |
RGD:6480464 |
CTD |
| G |
Sstr2 |
somatostatin receptor 2 |
|
decreases expression |
EXP |
10 |
103,246,880 |
103,254,444 |
RGD:6480464 |
CTD |
| G |
St8sia3 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 |
|
decreases expression |
EXP |
18 |
60,467,773 |
60,474,264 |
RGD:6480464 |
CTD |
| G |
Stag2 |
stromal antigen 2 |
|
decreases expression |
ISO |
X |
2,840,102 |
2,970,905 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
decreases expression |
EXP |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Steap2 |
STEAP family member 2, metalloreductase |
|
increases expression |
EXP |
4 |
25,034,176 |
25,053,800 |
RGD:6480464 |
CTD |
| G |
Stx5 |
syntaxin 5 |
|
increases expression |
EXP |
1 |
211,409,653 |
211,426,725 |
RGD:6480464 |
CTD |
| G |
Sulf1 |
sulfatase 1 |
|
decreases expression |
EXP |
5 |
5,582,896 |
5,748,106 |
RGD:6480464 |
CTD |
| G |
Sycp3 |
synaptonemal complex protein 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Syna |
syncytin a |
|
increases expression |
EXP |
12 |
23,220,471 |
23,222,327 |
RGD:6480464 |
CTD |
| G |
Synpr |
synaptoporin |
|
decreases expression |
EXP |
15 |
13,135,331 |
13,314,004 |
RGD:6480464 |
CTD |
| G |
Synrg |
synergin, gamma |
|
decreases expression |
EXP |
10 |
72,247,720 |
72,330,036 |
RGD:6480464 |
CTD |
| G |
Syt6 |
synaptotagmin VI |
|
decreases expression |
EXP |
2 |
198,807,340 |
198,862,227 |
RGD:6480464 |
CTD |
| G |
Syt9 |
synaptotagmin IX |
|
decreases expression |
EXP |
1 |
164,722,168 |
164,928,937 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
affects expression |
EXP |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tac4 |
tachykinin 4 (hemokinin) |
|
decreases expression |
EXP |
10 |
83,946,235 |
83,954,475 |
RGD:6480464 |
CTD |
| G |
Tacr3 |
tachykinin receptor 3 |
|
increases expression |
EXP |
2 |
232,309,015 |
232,404,964 |
RGD:6480464 |
CTD |
| G |
Taf1 |
TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor |
|
decreases expression |
ISO |
X |
89,590,556 |
89,666,569 |
RGD:6480464 |
CTD |
| G |
Tbl1xr1 |
transducin (beta)-like 1 X-linked receptor 1 |
|
decreases expression |
EXP |
2 |
107,561,415 |
107,688,872 |
RGD:6480464 |
CTD |
| G |
Tcf4 |
transcription factor 4 |
|
decreases expression |
EXP |
18 |
66,135,863 |
66,359,984 |
RGD:6480464 |
CTD |
| G |
Tenm2 |
teneurin transmembrane protein 2 |
|
decreases expression |
EXP |
10 |
20,939,207 |
21,888,443 |
RGD:6480464 |
CTD |
| G |
Terf2 |
telomeric repeat binding factor 2 |
|
decreases expression |
ISO |
19 |
36,930,490 |
36,958,589 |
RGD:6480464 |
CTD |
| G |
Tesk2 |
testis-specific kinase 2 |
|
increases expression |
EXP |
5 |
137,014,118 |
137,100,429 |
RGD:6480464 |
CTD |
| G |
Tgfa |
transforming growth factor alpha |
|
increases expression |
ISO |
4 |
120,355,649 |
120,437,772 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
increases expression |
ISO |
13 |
102,718,703 |
102,818,768 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
increases activity |
EXP |
3 |
148,832,866 |
148,862,385 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
increases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
increases expression |
ISO |
7 |
19,677,144 |
19,727,072 |
RGD:6480464 |
CTD |
| G |
Tmeff1 |
transmembrane protein with EGF-like and two follistatin-like domains 1 |
|
decreases expression |
EXP |
5 |
65,271,278 |
65,357,296 |
RGD:6480464 |
CTD |
| G |
Tmod2 |
tropomodulin 2 |
|
decreases expression |
EXP |
8 |
80,392,806 |
80,419,315 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases secretion |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
increases expression |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnr |
tenascin R |
|
decreases expression |
EXP |
13 |
75,271,116 |
75,347,181 |
RGD:6480464 |
CTD |
| G |
Tob2 |
transducer of ERBB2, 2 |
|
decreases expression |
EXP |
7 |
120,200,815 |
120,209,535 |
RGD:6480464 |
CTD |
| G |
Top2b |
topoisomerase (DNA) II beta |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tph1 |
tryptophan hydroxylase 1 |
|
increases expression |
EXP |
1 |
97,186,071 |
97,207,551 |
RGD:6480464 |
CTD |
| G |
Tph1 |
tryptophan hydroxylase 1 |
|
increases expression |
EXP |
1 |
97,186,071 |
97,207,551 |
RGD:6480464 |
CTD |
| G |
Trak2 |
trafficking protein, kinesin binding 2 |
|
decreases expression |
EXP |
9 |
57,474,682 |
57,540,751 |
RGD:6480464 |
CTD |
| G |
Trip12 |
thyroid hormone receptor interactor 12 |
|
decreases expression |
ISO |
9 |
83,961,411 |
84,085,077 |
RGD:6480464 |
CTD |
| G |
Tsn |
translin |
|
decreases expression |
EXP |
13 |
30,917,400 |
30,928,092 |
RGD:6480464 |
CTD |
| G |
Ttbk2 |
tau tubulin kinase 2 |
|
increases expression |
EXP |
3 |
107,517,280 |
107,623,425 |
RGD:6480464 |
CTD |
| G |
Txnl4a |
thioredoxin-like 4A |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ubc |
ubiquitin C |
|
increases expression |
EXP |
12 |
32,333,211 |
32,337,944 |
RGD:6480464 |
CTD |
| G |
Ube2i |
ubiquitin-conjugating enzyme E2I |
|
increases expression |
ISO |
10 |
14,509,948 |
14,524,551 |
RGD:6480464 |
CTD |
| G |
Ubox5 |
U-box domain containing 5 |
|
increases expression |
ISO |
3 |
118,217,774 |
118,260,594 |
RGD:6480464 |
CTD |
| G |
Uchl3 |
ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase) |
|
decreases expression |
EXP |
15 |
85,628,490 |
85,670,420 |
RGD:6480464 |
CTD |
| G |
Usp2 |
ubiquitin specific peptidase 2 |
|
increases expression |
ISO |
8 |
47,052,085 |
47,076,321 |
RGD:6480464 |
CTD |
| G |
Usp33 |
ubiquitin specific peptidase 33 |
|
decreases expression |
ISO |
2 |
250,885,728 |
250,920,082 |
RGD:6480464 |
CTD |
| G |
Usp7 |
ubiquitin specific peptidase 7 (herpes virus-associated) |
|
increases expression |
ISO |
10 |
6,917,612 |
6,963,452 |
RGD:6480464 |
CTD |
| G |
Usp9x |
ubiquitin specific peptidase 9, X-linked |
|
decreases expression |
ISO |
X |
21,606,330 |
21,718,042 |
RGD:6480464 |
CTD |
| G |
Vipr1 |
vasoactive intestinal peptide receptor 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Vnn1 |
vanin 1 |
|
increases expression |
EXP |
1 |
22,087,290 |
22,097,592 |
RGD:6480464 |
CTD |
| G |
Vwa5b1 |
von Willebrand factor A domain containing 5B1 |
|
increases expression |
EXP |
5 |
157,374,009 |
157,428,939 |
RGD:6480464 |
CTD |
| G |
Wnt1 |
wingless-type MMTV integration site family, member 1 |
|
affects expression |
EXP |
7 |
137,557,836 |
137,561,883 |
RGD:6480464 |
CTD |
| G |
Wnt10b |
wingless-type MMTV integration site family, member 10B |
|
affects expression |
EXP |
7 |
137,541,197 |
137,547,000 |
RGD:6480464 |
CTD |
| G |
Wnt2 |
wingless-type MMTV integration site family member 2 |
|
decreases expression |
EXP |
4 |
43,649,783 |
43,689,596 |
RGD:6480464 |
CTD |
| G |
Wnt2b |
wingless-type MMTV integration site family, member 2B |
|
increases expression |
EXP |
2 |
200,218,630 |
200,233,002 |
RGD:6480464 |
CTD |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
decreases expression |
EXP |
16 |
3,782,025 |
3,799,625 |
RGD:6480464 |
CTD |
| G |
Wnt9a |
wingless-type MMTV integration site family, member 9A |
|
decreases expression |
EXP |
10 |
45,613,668 |
45,641,488 |
RGD:6480464 |
CTD |
| G |
Wnt9b |
wingless-type MMTV integration site family, member 9B |
|
decreases expression |
EXP |
10 |
92,880,020 |
92,901,641 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
decreases expression |
EXP |
X |
3,011,520 |
3,047,798 |
RGD:6480464 |
CTD |
| G |
Ythdf2 |
YTH domain family, member 2 |
|
decreases expression |
EXP |
5 |
151,063,958 |
151,089,250 |
RGD:6480464 |
CTD |
| G |
Zbtb16 |
zinc finger and BTB domain containing 16 |
|
increases expression |
ISO |
8 |
51,931,530 |
52,094,813 |
RGD:6480464 |
CTD |
| G |
Zdhhc20 |
zinc finger, DHHC-type containing 20 |
|
decreases expression |
EXP |
15 |
36,879,173 |
36,934,987 |
RGD:6480464 |
CTD |
| G |
Zdhhc21 |
zinc finger, DHHC-type containing 21 |
|
decreases expression |
EXP |
5 |
101,682,165 |
101,730,978 |
RGD:6480464 |
CTD |
| G |
Zdhhc23 |
zinc finger, DHHC-type containing 23 |
|
decreases expression |
EXP |
11 |
58,286,189 |
58,296,769 |
RGD:6480464 |
CTD |
| G |
Zeb1 |
zinc finger E-box binding homeobox 1 |
|
increases expression |
ISO |
17 |
60,177,150 |
60,198,584 |
RGD:6480464 |
CTD |
| G |
Zfp386 |
zinc finger protein 386 (Kruppel-like) |
|
decreases expression |
EXP |
6 |
143,311,722 |
143,326,401 |
RGD:6480464 |
CTD |
| G |
Zfp622 |
zinc finger protein 622 |
|
decreases expression |
EXP |
2 |
77,571,866 |
77,585,706 |
RGD:6480464 |
CTD |
| G |
Zfp644 |
zinc finger protein 644 |
|
decreases expression |
EXP |
14 |
3,645,610 |
3,720,694 |
RGD:6480464 |
CTD |
| G |
Zfp91 |
zinc finger protein 91 |
|
decreases expression |
EXP |
1 |
215,846,158 |
215,882,704 |
RGD:6480464 |
CTD |
| G |
Zic1 |
Zic family member 1 |
|
decreases expression |
ISO |
8 |
96,314,692 |
96,318,130 |
RGD:6480464 |
CTD |
| G |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
|
decreases expression |
EXP |
16 |
1,037,882 |
1,245,259 |
RGD:6480464 |
CTD |
| G |
Znrf1 |
zinc and ring finger 1, E3 ubiquitin protein ligase |
|
increases expression |
ISO |
19 |
41,455,386 |
41,537,955 |
RGD:6480464 |
CTD |
Term paths to the root
|